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Interaction of representative [Au(alkyldiamine)Cl2]Cl complexes were 
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DL-pencillamine, thiomalic acid and glutathione, thiones e.g. ergothioneine, 
imidazolidien-2-thiones and its derivatives i.e. diazinane-2-thione and diazipan-2-
thione, thioether and selenoether e. g. methionine and seleno-methionine in 
addition to imidazole and histidine ligands.  
A series of aurocyanide and auricyanide complexes of phosphines, 
phosphine sulphides and phosphine selenides ligands were synthesized. 
These reactions were monitored using UV-Vis, Far and med-IR, 1H and 
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The results obtained from this work will provide better understanding of 
the gold(III) chemistry, which will help to design better medicinally important 
complex. 
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ﺍﻟﺨﻼﺻﺔ 
ﺍﻷﺳﻢ: ﺑﺎﺳﻢ ﻋﺒﺪﺍﻟﻠﻄﻴﻒ ﺍﻟﻤﻴﺜﻠﻮﻧﻲ 
ﺍﻷﻣﻴﻦ ﻭ ﺍﻟﺴﻴﺎﻧﻴﺪ ﻭ –( ﻣﻊ ﻣﺮﺗﺒﻄﺎﺕ ﺍﻷﻛﻴﻞ-ﺛﻨﺎﺋﻲ3ﺗﺤﻀﻴﺮ ﻣﻌﻘﺪﺍﺕ ﺟﺪﻳﺪﺓ ﻣﻦ ﺍﻟﺬﻫﺐ)+ ﻋﻨﻮﺍﻥ ﺍﻟﺪﺭﺍﺳﺔ:
ﺗﻔﺎﻋﻼﺗﻬﺎ ﻣﻊ ﻣﺮﺗﺒﻄﺎﺕ ﺫﺍﺕ ﺃﻫﻤﻴﺔ ﺑﻴﻮﻟﻮﺟﻴﺔ. 
 ﺍﻟﻤﺠﺎﻝ: ﺍﻟﻜﻴﻤﻴﺎء
  ﻡ0102ﺗﺎﺭﻳﺦ ﺍﻟﺪﺭﺟﺔ: ﻣﺎﻳﻮ 
+( ﺗﻢ ﺗﺤﻀﻴﺮﻫﺎ ﻋﻦ 3ﻏﻴﺮ ﺍﻟﻤﺘﺠﺎﻧﺴﺔ ﻟﻠﺬﻫﺐ )ﺍﻝ  ﺍﻟﺨﻤﺎﺳﻴﺔ ﻭ ﺍﻟﺴﺪﺍﺳﻴﺔ ﻭ ﺍﻟﺴﺒﺎﻋﻴﺔﺳﻠﺴﻠﺔ ﻣﻦ ﺍﻟﻤﺮﻛﺒﺎﺕ ﺍﻟﺤﻠﻘﻴﺔ
 ﻭ )ne( enimaidenelyhte ﻣﻊ ﻣﻜﺎﻓﺌﻬﺎ ﻣﻦ ﺍﻟﻤﺮﺗﺒﻄﺎﺕ )O2H3•4lCuAH( dica ciruAﻃﺮﻳﻖ ﻣﻔﺎﻋﻠﺔ 
 ﻭ ﻣﺸﺘﻘﺎﺗﻬﺎ ne ﺑﺎﻻﺿﺎﻓﺔ ﻟﻌﺪﺩ ﻣﻦ ﻣﺮﻛﺒﺎﺕ  )nb( enimaidenelytub ﻭ  )np( enimaidenelyporp
 ﻟﻘﺪ ﺗﻢ ﺗﺸﺨﻴﺺ ﺍﻟﻤﺮﻛﺒﺎﺕ .-]4)NC(uA[, ﺍﺿﺎﻓﺔ ﺍﻟﻰ ﻣﺮﻛﺐ ﺃﺣﺎﺩﻳﺔ ﻭ ﺛﻨﺎﺋﻴﺔ ﺍﻻﺳﺘﺒﺪﺍﻝ ﻋﻠﻰ ﺍﻟﻨﻴﺘﺮﻭﺟﻴﻦ
ﺍﻟﻤﺤﻀﺮﺓ ﺑﺈﺳﺘﺨﺪﺍﻡ ﻓﺤﺺ ﺩﺭﺟﺔ ﺍﻻﻧﺼﻬﺎﺭ ﻭﺗﺤﻠﻴﻞ ﺍﻟﻌﻨﺎﺻﺮ ﻭ ﻟﻘﺪ ﺗﻢ ﺩﺭﺍﺳﺔ ﺑﻨﻴﺔ ﺍﻟﻤﺮﻛﺒﺎﺕ ﺍﻟﻤﺤﻀﺮﺓ 
 ﻓﻲ ﺍﻟﺤﺎﻟﺔ ﺍﻟﺴﺎﺋﻠﺔ C31 ﻭ H1 ﻟﺬﺭﺍﺕ RMN ﻭ ﺗﺤﻠﻴﻞ RI  ﻭ RI-raF ﻭ siV-VUﺑﺎﺳﺘﺨﺪﺍﻡ ﺍﻟﺘﺤﻠﻴﻞ ﺍﻟﻄﻴﻔﻲ 
 . ﺻﻴﻐﺔ ﻣﺮﻛﺒﺎﺕ.  ﺑﺎﻟﺤﺎﻟﺔ ﺍﻟﺼﻠﺒﺔN51 ﻭ C31ﺑﺎﻻﺿﺎﻓﺔ ﺍﻟﻰ ﺫﺭﺍﺕ 
ﻟﻘﺪ ﺗﻢ ﺩﺭﺍﺳﺔ ﺗﻔﺎﻋﻼﺗﻬﺎ ﻣﻊ ﻣﺮﻛﺒﺎﺕ ﺛﻴﻮﻝ ﺫﺍﺕ ﺃﻫﻤﻴﺔ ﺑﻴﻮﻟﻮﺟﻴﺔ ﻣﺜﻞ ﺍﻟﺴﻴﺴﺘﻴﻦ, ﺍﻟﺒﻨﺴﻠﻤﻴﻦ, ﺣﻤﺾ 
-ﺛﻴﻮﻥ ﻭ 2-ﺛﻨﺎﺋﻲ ﺍﻟﺜﻴﻮﻳﻮﺭﺍﺳﻴﻞ, ﺍﻳﻤﻴﺪﺍﺯﻭﻟﺪﻳﻦ-4,2ﺍﻻﺭﺟﻮﺛﻴﻮﻧﻴﻦ, ﻥ ﺍﻟﺜﻴﻮﻣﺎﻟﻴﻚ ﻭﺍﻟﺠﻠﻮﺗﺎﺛﻴﻮﻥ ﻭﻣﺮﻛﺒﺎﺕ ﺍﻟﺜﻴﻮ
ﻳﺜﺮ ﻣﺜﻞ ﺍﻟﻤﻴﺜﻴﻮﻧﻴﻦ ﻭ ﺍﻟﺴﻴﻠﻴﻨﻮ ﻣﻴﺜﺎﻳﻮﻧﻴﻦ ﻭ ﺉﻳﺜﺮ ﻭ ﺍﻟﺴﻴﻠﻴﻨﻮ ﻣﺮ ﻛﺒﺎﺕ ﺍﻟﺜﻴﻮﺉ-ﺛﻴﻮﻥ2ﻣﺸﺘﻘﺎﺗﻬﺎ, ﺍﻟﺪﻳﺎﺯﻳﻨﺎﻥ-
 ﺑﺎﻻﺿﺎﻓﺔ ﺍﻟﻰ ﺍﻻﻳﻤﻴﺪﺍﺯﻭﻝ ﻭ ﺍﻟﻬﺴﺘﺪﻳﻦ.
ﻟﻘﺪ ﺗﺤﻀﻴﺮ ﺳﻠﺴﻠﺔ ﻣﻦ ﻣﻌﻘﺪﺍﺕ ﺍﻟﻔﻮﺳﻔﻴﻦ ﻭ ﺍﻟﻔﻮﺳﻔﻴﻦ ﺳﻠﻔﺎﻳﺪ ﻭ ﺍﻟﻔﻮﺳﻔﻴﻦ ﺳﻴﻠﻴﻨﺪ ﺍﻷﻭﺭﻭﺳﻴﺎﻧﻴﺪ 
 ﻭﺍﻷﻭﺭﻳﺴﻴﺎﻧﻴﺪ.
 ﻭ ﺗﺤﻠﻴﻞ RI  ﻭ RI-raF ﻭ siV-VUﻟﻘﺪ ﺗﻢ ﻣﺘﺎﺑﻌﺔ ﺍﻟﺘﻔﺎﻋﻼﺕ ﺑﺎﺳﺘﺨﺪﺍﻡ ﺍﻟﺘﺤﻠﻴﻞ ﺍﻟﻄﻴﻔﻲ ﻣﺜﻞ 
  ﺑﺎﻟﺤﺎﻟﺔ ﺍﻟﺼﻠﺒﺔ. N51 ﻭ C31 ﻓﻲ ﺍﻟﺴﺎﺋﻠﺔ ﺑﺎﻻﺿﺎﻓﺔ ﺍﻟﻰ ﺫﺭﺍﺕ C31 ﻭ H1 ﻟﺬﺭﺍﺕ RMN
( ﻣﻤﺎ ﺳﻴﺴﺎﻋﺪ ﻓﻲ ﺗﺼﻤﻴﻢ ﻣﻌﻘﺪﺍﺕ 3)+ ﻧﺘﺎﺋﺞ ﻫﺬﻩ ﺍﻟﺪﺭﺍﺳﺔ ﺳﻮﻑ ﺗﻘﺪﻡ ﻓﻬﻢ ﺃﻓﻀﻞ ﻟﻜﻴﻤﻴﺎء ﺍﻟﺬﻫﺐ
 ﺃﻓﻀﻞ  ﺫﺍﺕ ﺃﻫﻤﻴﺔ ﻃﺒﻴﻪ.
ﺩﺭﺟﺔ ﺍﻟﺪﻛﺘﻮﺭﺍﻩ ﻓﻲ ﺍﻟﻔﻠﺴﻔﺔ 
ﺟﺎﻣﻌﺔ ﺍﻟﻤﻠﻚ ﻓﻬﺪ ﻟﻠﺒﺘﺮﻭﻝ ﻭ ﺍﻟﻤﻌﺎﺩﻥ 
ﺍﻟﻈﻬﺮﺍﻥ-ﺍﻟﻤﻤﻠﻜﺔ ﺍﻟﻌﺮﺑﻴﺔ ﺍﻟﺴﻌﻮﺩﻳﺔ 
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CHAPTER ONE 
INTRODUCTION 
Cis-platin was one of the first metal complexes used for cancer treatment with its 
anti-cancer activity discovered in the 1960s [1-3].  It is responsible for the cure of 
more than 90 % of testicular cancer cases and plays a vital role in the treatment of 
cancers such as ovarian, head & neck cancer, bladder cancer, cervical cancer, 
melanoma, and lymphomas [4]. 
Because platinum(II) complexes have exhibited such promising results 
against selected types of cancers, several families of non-platinum metal 
complexes have been studied intensely as potential cytotoxic and antitumor 
agents. Gold(III) is isoelectronic with platinum(II) and tetracoordinate gold(III) 
complexes have the same square-planar geometries as cis-platin [5]. They are 
known to have antimicrobial activity [6,7], therapeutic effect [8] and they are used 
in metal-based drugs [9,10].  Recently, gold(III) complexes of N-donor ligands 
showed anti-tumor effect at the preclinical results [11]. However, compared to the 
corresponding platinum(II) complexes, gold(III) complexes have not been well 
explored chemically possibly because few gold(III) complexes have been shown 
to be sufficiently stable in aqueous solution [12]. 
Gold complexes exist predominantly as gold(I) in-vivo [13-15]. Thioethers, 
peptide and L-methionine residues as well as disulfide bonds are able to reduce 
gold(III) to gold(I). Aurosomes (i.e., lysosomes of phagocytic, liver, and kidney 
cells with large accumulations of gold), isolated from gold(III)-treated rats as well 
as those treated with gold(I), contain predominantly gold(I). The bulk of gold in-
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vivo is therefore likely to be gold(I). So gold(I) chemistry attracts most of the 
attention until recent decade because of its stability. Nonetheless, under 
biomimetic conditions, gold(I) can be oxidized to gold(III) in-vivo [16]. Recently, 
extensive work was published involving gold(III) chemistry which found application 
in anticancer drugs [16]. 
Ethylenediamine (en) ligand is a common chelating ligand, for which the 
chemistry and reactivity with gold metal have been studied since 1931 by Gibson 
et al [17], in addition to gold(III)-ethylenediamine complex, other gold(III) 
complexes with similar chelating ligands such as  propylenediamine (pn) and 
butylenediamine (bn) ligands were prepared. The exchange and substitution 
reactions of these complexes with some bioligands were investigated, because of 
their similarities to cis-platin. These alkyldiamines are expected to cause blocking 
of the two cis positions of the square planar structure and make the other two 
positions available for coordination and bonding to bioligands, as for cis-platin.  In 
addition, stabilization of gold(III) oxidation state and square planar structure is 
achieved using such chelating ligands. Synthesis and characterization of a range 
of Au(III) complexes and derivatives with various unsubstituted and N,N'-
disubstituted alkyldiamine ligands (Schemes 1.1-3) are presented.  
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Scheme 1.1: [Au(alkyldiamine)Cl2]+ complexes, where R, R' could be H or alkyl 
groups such as Me, Et, 2-hydroxy-Et, Pr and iPr. 
 
Scheme 1.2: [Au(N-substituted-en)Cl2]+ complexes. 
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Scheme 1.3: [Au(N,N'-di-substituted-en)Cl2]+ complexes. 
Gold applications in medicinal chemistry were found mainly for Au(I).  
Recently Au(II) was suggested to be stable while binding to hematoporphyrin [18], 
while Au(III) found very important applications in medicinal chemistry in spite of 
finding hindrance of improvement by the low stability in side tissues as reported by 
Ott [11]. 
Ethylenediamine-gold(III) complex [Au(en)Cl2]Cl was prepared and 
characterized by Zhu and co-workers. Single crystal X-Ray structure was reported 
[5], which was found to have square-planar geometry around Au(III) metal center. 
Chloride atoms were shown to be located at two cis corners of the square planer 
base. 
Tiekink [19] reported a full range of gold compounds currently being 
investigated for their potential anti-tumor activity. Gold(I) compounds related to the 
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anti-arthritic drug Auranofin continue to attract attention, especially those carrying 
biologically active molecules with anti-tumor activity. 
Tetrahedrally coordinated gold(I) compounds, that possibly target 
mitochondria, are under development with a particular focus upon moderating 
their hydrophilicity. The interest in square-planar gold(III) compounds has 
increased in the last decade. A wide variety of species: mono- and di-nuclear, 
neutral and charged, coordination and organometallic, etc. are being developed. 
Many investigations and studies of mechanistic aspects of gold compounds where 
conducted but a clear understanding of the mechanism of action of these 
compounds has yet to be determined.  
 Gabbiani, et al [20] have recently reported the synthesis as well as 
cytotoxic studies of some ethylenediammine gold(III) complexes. They found that 
the mechanisms of action of cytotoxic gold(III) complexes seem to be innovative 
and substantially different from that of cis-platin.  This as well as related other 
recent studies [21] lead us to synthesize series of unsubstituted ethylenediammine 
along with another group of N-mono-substituted as well as N,N'-disubstituted 
ethylenediamine ligands with AuCl4-.  The ligands used here are ethylenediamine 
(en), propylene diamine (pn) and butylenediamine (bn) ligands, N-Me-en, N-Et-en, 
N-iPr-en, N-hydroxy-Et-en and N,N'-di-substituted ethylenediamine ligands, such 
as N,N'-Me2-en, N,N'-Et2-en, N,N'-(iPr)2-en and N,N'-(2-hydroxy-Et)2-en. The 
general formula of these complexes is [Au(alkanediamine)Cl2]Cl.   
In [Au(en)Cl2]Cl complex, gold(III) is blocked by en ligand from two 
coordination sites and only two Cl- ligands are available for reaction. Therefore, it 
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will be of interest to see the difference in reactivity between two types of gold(III) 
complexes, with and without the en ligand.  
Notable results for the appearance of new potential anti-tumor application 
of these gold(III) complexes reported in literature. They showed promising 
cytotoxic properties toward cancer cells, both in-vitro and in-vivo studies [22]. 
Several derivatives of multi-dentate ligands were used to build square planar 
gold(III) complexes [23,24].  
Anticancer activities of any antitumor complex depend on its interaction 
with DNA [25], so its reaction with other molecules in biological fluid will prevent 
these compounds from reaching the targeted organs [26].  Several complexes 
with chelating ligands such as pyrazolyl on palladium(II), platinum(II) and gold(III) 
metal were prepared by Keter et al and found to be exchanged by cysteine [25], 
they also reported  that gold(III) complexes targeted molecules other than DNA as 
also reported by Marcon  et al [27], so these side interactions will decrease its 
activity as well as its efficiency.  
Gold complexes were used as anti-arthritic drug such as auranofin and 
myocrisin [28-31].  Anti-rheumatic gold complexes are activated by their 
conversion into aurocyanide [Au(CN)2]- [32], this stimulates investigation of 
aurocyanide complexes interaction with various bioligands, especially that contain 
sulfur because of the known gold-sulfur affinity [33,34]. While auricyanide 
[Au(CN)4]- was considered previously as metabolic product of anti-arthritic gold(I) 
in-vivo [16], however, low stability of gold(III) complexes limited their medical 
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importance. Heavier chalcogens-gold chemistry is still an unexplored field of 
modern inorganic chemistry [35]; this could be attributed to their lower stability. 
Inhalation of HCN from tobacco smoke raises [Au(CN)2]− concentration in 
smokers blood who takes gold(I) anti-arthritic drug [36]. Large formation constant 
is believed to be responsible for generating [Au(CN)2]−, (log β = 36.6-39) [37-39]. 
Graham et al have reported aurothiomalate (Autm) activation through its 
interaction with cyanide ion [40], this interaction was found to increase red blood 
cells uptake of gold from gold(I)-thiomalate by 21.1% after incubation for 24 hours 
[39,40].  
In a study of [Au(CN)4]- reaction with GSH three potential mechanisms 
were suggested for auricyanide reduction into aurocyanide [16,41];(i) Reductive 
elimination of cyanogen, followed by nucleophilic attack of GSH on cyanogen 
leading to its reduction to cyanide [42]; (ii) Formation of hexacyanodiaurate(II), 
[(NC)3Au–Au(CN)3]2-, probably by 2 one-electron transfers, followed by redox 
disproportionation [43,44] and (iii) cyanide ligand exchange by GSH followed by 
reductive elimination of GSSG. 
The first generation injectable drugs solganal (gold thioglucose, AuSTg) 
and myochrysine (gold sodium thiomalate, AuSTm) followed by the second 
generation orally administered auranofin (2,3,4,6-tetra-O-acetyl-β-1-D-
Thioglucopyranosato-S-(triethylphosphine))gold(I), (Et3PAuSATg) [16] have been 
developed. Both Solganal and auranofin bind to albumin by exchange of its 
tetraactyl thioglucose ligand by L-cysteine [45]. Despite being used for over 70 
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years for rheumatoid arthritis treatment, gold complexes anti-cancer potential has 
been recently suggested [46]. 
Bio-ligands containing sulfur such cysteine, pencillamine, glutathione, 
methionine, thiones etc. have a strong gold(III) affinity so it is of great important to 
evaluate the proposed antitumor complexes according to their interaction with 
sulfur containing bioligands [47].  
Gold-sulfur complexes are very important building blocks that are used in 
many important applications in medicine as in anti-arthritic drugs, such as 
auranofin. Thione ligands are simple sulfur containing ligands, their heterocyclic 
rings with various metal ions have received much attention [48,49]. A variety of 
gold-sulfur complexes has been prepared and utilized for many applications e.g. 
pharmacological, thin film, glass, and ceramic applications [50-52].  
Thiols are known to be very reactive with gold complexes [53,54]  e.g. AuS2 
coordination environment was reported to be formed by bridging thiolate (RS-) 
ligands between two gold(I) ions forming oligomer [55], more thiol ligand added 
found to cause formation of simpler complexes as [Au(SR)2]- [55]. 
It was reported by Shmidbaur that gold(III) reacts with glutathione in two 
steps. Gold(III) is first reduced to gold(I) then glutathione acts as a bridge between 
two gold(I) units through sulfur forming macro-clusters (Scheme 1.4). This 
structure is promoted by aurophilicity [56].   
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Scheme 1.4: Gold(I)–GS cluster. 
Thiols were reported to be oxidized into the disulfides [57], while gold 
complexes were found to cause oxidative cleavage of proteins and peptides 
disulfide into sulphoinic acid; this reaction is reported to be responsible for gold 
toxicity [58-61]. 
Thiones like imidazolidine-2-thione (Imt), diazinane-2-thione (Diaz) and 
diazipane-2-thione (Diap) (Scheme 1.5) have different coordination sites (through 
S and N), these ligation sites can provide various coordination modes that can 
give different properties for complex, that can be useful for different applications 
[50]. 
 
 
Scheme 1.5: (a) Imt, (b) diaz and (c) Diap. 
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Interaction of gold(I) with thiones have been explored well in literature 
[52,62,63], while less attention was given for gold(III) complexes. This may be due 
to lower stability of the gold(III) than the gold(I) complexes. This has lead to much 
scarce knowledge about Au(III) complexes interaction with biological ligands. 
However, gold(III) was found to be resilient in vivo by oxidative bursts [19] that can 
oxidize gold(I) to gold(III) by the help of the enzyme myeloperoxidase [19]. 
Gold(III)-tetracyanide was considered as a metabolic product of anti-arthritic and 
anti-rheumatic drugs [16], which found latter to increase cell uptake of drug 
[39,40].  
Several researches were conducted concerning mechanistic aspects of 
gold complexes in-vivo [59]. Application and usage as anticancer drug where also 
discussed by several reports [1,59].  
In order to determine the mechanism of action of the anti-arthritic gold 
complexes, it is necessary to understand the physiochemical properties of these 
complexes and their reactivity under physiological conditions. 
By exploring the properties and reactivities of gold(III) complexes it is expected 
that this will provide a wider choice of drugs, which would avoid the severe side 
effects of cis-platin as well as trying to get higher activity toward tumor resistance 
[1].  
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CHAPTER TWO 
OBJECTIVES 
2.1 Synthesis and characterization. 
1. Gold(III) mono-alkyldiamine complexes [Au(L)Cl2]Cl and [Au(L)2]Cl3 will be 
synthesized, L is ethylenediamine (en), propylenediamine (pn) and 
butylenediamine (bn). These complexes will be prepared as 15N labeled and 
unlabeled ligands.   
2. Complexes of nitrogen substituted ethylenediamine will be synthesized: 
[Au(R,R'-en)Cl2]Cl.  R and R' are Me, Et, n-Pr, i-Pr etc. 
3. [Au(13C15N)4]- will be synthesized by adding 4 equivalents of  13C15N- to Au(III) 
halide. 
4. The complexes will be characterized using melting point, elemental analysis, 
Mid-IR, Far-IR, UV-Vis, X-ray, solution and solid state NMR techniques. 
2.2  Interactions of alkyldiamine gold(III) complexes with bioligands. 
1. Interaction of these complexes with labeled L-cysteine-13C3, glutathione, 
captopril, thiomalic acid, penicillamine etc. will be studied by 1H and 13C NMR.  
2. Interactions of these complexes with L-methionine-13C5, DL-seleno-
methionine-13C5) will be studied by 1H and 13C NMR.  
3. Interactions of Au(III) complexes with ergothionine, imidazolidine-2-thione and 
its derivatives will be studied by 1H and 13C NMR.  
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4. Interactions of these complexes with imidazole and L-histidine will be studied 
by 1H and 13C NMR. 
2.3  Interactions of [Au(13C15N)4]- complex with bioligands.  
1. Interaction of [Au(13C15N)4]-  with thiols such as L-cysteine, glutathione, 
captopril etc, and thioether such as L-methionine and DL-seleno-methionine 
will be studied by 1H, and 13C  NMR. 
2. Interaction of [Au(13C15N)4]-  with imidazolidine-2-thione (Imt) and its derivatives 
will be studied by 1H and 13C NMR. 
3. Interaction of [Au(13C15N)4]-  with phosphines such as (2-CN-Et)3P, Cy3P will be 
studied by 1H, 13C and 31P NMR. 
4. Interaction of [Au(13C15N)4]-  with phosphine sulfides such as Me3PS, Et3PS, 
Ph3PS will be studied by 1H, 13C and 31P NMR. 
5. Interaction of [Au(13C15N)4]- with phosphine selenides such as Me3PSe, 
Ph3PSe will be studied by 1H, 13C and 31P NMR.  
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CHAPTER THREE 
EXPERIMENTAL 
3. 1 Chemicals 
Reagents and solvents were used as received from commercial sources. The 
synthesized compounds were identified by melting point, elemental analysis, IR 
and NMR spectroscopy techniques.   
HAuCl4.3H2O was obtained from Strem Chemicals Co., while acetone, 
absolute ethanol, acetonitrile, D2O and CD3OD were obtained from Fluka 
Chemicals Co, ligands e.g. ethylenediamine (en), propylenediamine (pn), 
butylenediamine (bn), L-glutathione, L-captopril, thiomalic acid, DL-penicillamine, 
ergothionine, 2,4-dithiouracil, imidazolidine-2-thione (Imt), 1,3-Diazinane-2-thione 
(Diaz), 1,3-diazipane-2-thione (Diap), imidazole, L-histidine and L-glycine were 
obtained from Sigma-Aldrich, L-13C3-cysteine, L- methionine-13C5, DL-Se-
methionine-13C5 were obtained from Isotech, USA. 
3.2.  UV measurements 
3.2.1  [Au(alkyldiamine)Cl2]Cl    
Electronic spectra where collected for the alkyldiamine gold(III) complexes using 
Lambda 200, Perkin-Elmer UV-Vis spectrometer.  
3.2.2  [Au(alkyldiamine)Cl2]Cl with L-histidine; Kinetic Measurements. 
Buffer solution was prepared from 0.01 M H3PO4 solution adjusted at pH 2.9.  This 
solution was used to prepare [Au(en)Cl2]Cl and L-histidine stock solution as 3.0 
mM of each, which were mixed at different ratios to give various concentrations as 
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3.00 mL total volume. Absorbance of the [Au(en)Cl2]Cl at 305 nm was monitored 
during the course of the reaction at 25 oC.  
 Fitting of the first 5-10 % of the UV-Vis absorbance change to linear 
equation gives the slope as the initial rate (vi, mol•L-1•s-1) for [Au(en)Cl2]+ complex 
and L-histidine interaction.  
3.2.3 [Au(13C15N)4]- reaction with L-cysteine, glutathione, captopril, L-
methionine and DL-Seleno-methionine. 
UV spectra in the range 200 to 330 nm (2 nm step size) for components of 0.1 mM 
concentration in phosphate buffer (100 mM) at pH = 7.4 at 25 oC were measured 
on GBC Cintra 303 spectrophotometer.  
3.3 Mid and Far-IR studies 
The solid-state IR spectra of the ligands and their gold(III) complexes were 
recorded on a Perkin–Elmer FTIR 180 spectrophotometer using KBr pellets over 
the range 4000–400 cm-1. Far-infrared spectra were recorded at 4 cm–1 resolution 
in the range 200-600 cm-1 at room temperature as Cesium Chloride disks on a 
Nicolet 6700 FT-IR with Far-IR beam splitter. 
3.4  1H, 13C and 15N NMR Spectroscopy  
3.4.1  NMR samples for [Au(alkyldiamine)Cl2]Cl complexes. 
NMR measurements were carried out on JEOL JNM-LA 500 MHz NMR 
spectrometer at 297 K using 0.10 M solution of the complexes in D2O. 13C NMR 
spectra were obtained at 125.65 MHz with 1H broadband decoupling. The spectral 
conditions were: 32k data points, 0.967s acquisition time, 1.00 s pulse delay and 
45o pulse angle, while 13C DEPT NMR spectra recorded at 135o pulse angle.  
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3.4.2  NMR samples for [Au(alkyldiamine)Cl2]Cl reaction with L-histidine and 
imidazole. 
NMR measurements were carried out on JEOL JNM-LA 500 MHz NMR 
spectrometer at 297 K using 0.10 M solution of the complexes in D2O. NMR 
samples were prepared by mixing 0.05 M of [Au(en)Cl2]Cl complex in D2O with 
0.05M L-histidine solution, pD was adjusted by DCl and NaOD solutions in D2O, 
pD raising of the [Au(en)Cl2]+ complex causes precipitation of hydrolysis products, 
such as metal hydroxide and oxides [10].  In order to avoid hydrolysis, pD was 
adjusted for L-histidine solution before mixing with [Au(en)Cl2]+ solution and 
measured again after mixing.  
Similarly for imidazole, samples were prepared by mixing solutions of 0.05 
M imidazole with 0.05 M [Au(en)Cl2]Cl.  DSS (2,2-dimethylsilapentane-5-
sulphonate) was used as internal reference for the 1H NMR.   
3.4.3.  NMR samples for [Au(en)Cl2]Cl reaction with L-methionine and DL-
seleno-methionine. 
NMR measurements were carried out on JEOL JNM-LA 500 MHz NMR 
spectrometer at 297 K using 0.10 M solution of the complexes in D2O. NMR 
samples were prepared by mixing D2O solutions of [Au(en)Cl2]Cl (0.05 M) and  
Met and Se-Met solution (0.05 M), pD were adjusted by DCl and NaOD solutions 
in D2O to pD = 3.8. 
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3.4.4 NMR samples for [Au(CN)4]- with thiols, L-methionine and DL-seleno-
methionine. 
NMR measurements were carried out on JEOL JNM-LA 500 MHz NMR 
spectrometer at 297 K using 0.10 M solution of the complexes in D2O. All NMR 
measurements were carried out by mixing 140 mM concentrations of reactants in 
D2O, reactants pD were adjusted to 7.4 before and after mixing. 13C NMR spectra 
were obtained at 125.65 MHz with 1H broadband decoupling. The spectral 
conditions were: 32 k data points, 0.967 s acquisition time, 1.00 s pulse delay, 45o 
pulse angle and 135o pulse angle for 13C DEPT NMR experiments.  
3.5  Solid State NMR Spectroscopy      
Solid-state NMR showed more sensitivity to coordination geometry rather than 
solution NMR, which is expected from the removal of the solvent effects, fluxional 
processes and other averaging processes that may be present in the solution 
state.  It has the added advantage that it provides the three principal components 
of the shielding tensor, rather than just the average value observed in solution 
spectra. These components can be calculated from the intensities of the spinning 
side bands in the solid-state spectra. Under the conditions of magic-angle 
spinning (MAS), the isotropic chemical shift δI, given by equation 1, is equivalent 
to the chemical shift observed in solution  
δI  = 1/3 (δ 11  +  δ22  +   δ33 )                 Eq  (1) 
For a nonsymmetrical environment, with  δ11  <     δ22   <      δ33  ,  the chemical 
shift anisotropy (∆δ) is defined as 
∆δ     =   δ33  - ½ ( δ11  +   δ22 )                Eq (2) 
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For a symmetric tensor, where  δ11  =       δ22  =  δ┴ , then δ33  =     δ// ;  for   δ33  
=    δ22 = δ┴ , then  δ11  =  δ// .  For these cases the shift anisotropy is defined as 
∆δ   =  δ//   -  δ┴                Eq 3 
Unlike solution chemical shifts, solid state NMR results can be correlated 
directly with crystallographic structure determinations when available, and 
structural predictions can be made in the absence of crystallographic data. 
3.5.1 Solid-state 13C NMR 
The 13C{1H} solid-state NMR spectra were obtained on a JEOL LAMBDA 500 
spectrometer operating at 125.65 MHz (11.74 T), at 25 oC. Samples were packed 
into 6 mm zirconium oxide rotors. Cross-polarization and high power decoupling 
were employed. Pulse delay of 7.0 s and a contact time of 5.0 ms were used in 
the CPMAS experiments. The magic angle spinning rates were from 2 kHz to 4 
kHz. Carbon chemical shifts were referenced to TMS by setting the high frequency 
isotropic peak of solid adamantane to 38.56 ppm.  
 
3.5.2 Solid-state 15N NMR 
Natural abundance 15N spectra were also recorded on the above machine, using a 
contact time of 5 ms and a pulse delay of 10 s. The magic angle spinning rates 
were between 2000 Hz to 4000 Hz. All 15N spectra were referenced to 15NH4NO3 
peak (δiso)= -358.63 ppm relative to CH3NO2, (δiso) =  0 ppm [64a]. Both the 15N 
spectra and 13C spectra, containing spinning side-band manifolds, were analyzed 
using a program HBA [64b] based on Maricq and Waugh [65] which developed at 
Dalhousie University, Canada, and University of Tübingen, Germany. 
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3.5.3 Solid-state 13P NMR 
Solid state cross-polarization magic-angle spinning CPMAS 31P{1H} NMR spectra 
were obtained at ambient temperature on the same spectrometer, operating at a 
frequency of 202.35 MHz. A contact time of 3 ms was used with a proton pulse 
width of 6 μs, with a recycle delay of 10 s. Chemical shifts were referenced using 
an external sample of solid PPh3 (δ = 8.40 ppm from 85 % H3PO4 ).  
Both 31P and 13C spectra, containing spinning side-band manifolds, were 
analyzed using a program HBA [64b] based on Maricq and Waugh [65] which 
were developed at Dalhousie University, Canada, and University of Tübingen, 
Germany. 
3.6 Synthesis and Preperation   
3.6.1 Synthesis of [Au(15N2en)Cl2]Cl, Au(15N2pn)Cl2]Cl , [Au(15N2bn)Cl2]Cl 
complexes and [Au(R or R2en)Cl2]Cl complexes, where R = Me, Et, n-Pr, i-Pr. 
All the complexes were prepared by dissolving of 0.25 mmol trihydrated auric 
tetrachloride HAuCl4.3H2O in minimum amount of absolute ethanol at ambient 
temperature.  In a separate beaker, solution of 0.25 mmol of the alkyldiamine in 
least amount of absolute ethanol was prepared, both solutions were mixed (total 
of ~ 20 mL) and stirred for around 30 minutes until clear solution obtained, which 
was filtered and concentrated to 10 ml volume then left for crystallization in the 
refrigerator.  The produced solid was dried under vacuum. The product was in the 
range of 51-67 % yield.  Abbreviations for prepared complexes are given in table 
3.1. Melting points and elemental analysis for complexes are presented in table 
3.2. 
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Table 3.1: abbreviations used for the new complexes. 
Complex Abbreviations 
[Au(en)Cl2]Cl 1a 
[Au(pn)Cl2]Cl 1b 
[Au(bn)Cl2]Cl 1c 
[Au(N-Me-en)Cl2]Cl 2a 
[Au(N-Et-en)Cl2]Cl 2b 
[Au(N-iPr-en)Cl2]Cl 2c 
[Au(N-hydroxyl-Et-en)Cl2]Cl 2d 
[Au(N,N'-Me2-en)Cl2]Cl 3a 
[Au(N,N'-Et2-en)Cl2]Cl 3b 
[Au(N,N'-iPr2-en)Cl2]Cl 3c 
[Au(N,N'-2-di-hydroxy-Et-en)Cl2]Cl 3d 
  
Table 3.2. Elemental analysis and of the prepared complexes  
  Found (Calc.) % 
Complex M. pt. (°C) H C N 
1a.2H2O 145-148 2.92(3.03) 6.22 (6.01) 6.79(7.01) 
1b.2H2O 190-193 3.50(3.42) 8.90(8.71) 6.90(6.78) 
1c.2H2O Dcmps.>230 4.25(4.08) 11.40(11.24) 6.70(6.55) 
2a.H2O 139-141 2.98(3.06) 8.95(9.11) 6.85(7.08) 
2b.2H2O 116-118 3.99(4.12) 13.33(13.60) 6.16(6.35) 
2d.2H2O 105-110 3.83(3.64) 11.00(10.83) 6.52(6.32) 
3a.H2O 80-83 3.83(3.78) 11.35(11.24) 6.61 (6.55) 
3b 106-109 3.95(3.85) 17.24(17.17) 6.84(6.68) 
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3.6.2 Synthesis of Au(III) complexes with thiones 
0.6 mmol [Au(alkyldiamine)Cl2]Cl was dissolved in 20 mL distilled H2O (solution 1). 
1.2 mmol of thione was dissolved in 40 mL methanol (solution 2). Both solutions 
were mixed in round bottom flask and refluxed at 60 oC for 4 hour. The resulting 
solution was filtered, concentrated and laid aside for crystallization. Products were 
characterized by m.pt and elemental analysis (Table 3.3). 
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Table 3.3: Elemental analysis of the prepared [Au(alkyldiamine)Cl2]+ with different 
substituted Imt, Diaz and Diap. 
   Found (Calc.) %  
Complex M.pt oC C H N S 
[(Imt)2Au(en)]Cl3 199-202 17.24(16.92) 3.73(3.55) 14.77(14.80) 11.19(11.30) 
[(Imt)2Au(pn)]Cl3 217-20 18.88(18.58) 4.16(3.81) 15.04(14.45) 11.04(11.02) 
[(Imt)2Au(bn)]Cl3 170-3 20.60(20.16) 4.20(4.06) 14.19(14.11) 9.97(10.76) 
[(Diaz)2Au(en)]Cl3 239-41 21.34(20.16) 4.70(4.06) 14.50(14.11) 9.91(10.76) 
[(Diaz)2Au(pn)2]Cl3 210-3 24.43(24.59) 5.06(5.31) 15.59(15.55) 10.30(9.38) 
[(Diaz)2Au(bn)]Cl3 268-71 23.18(23.31) 4.92(4.52) 13.50(13.47) 9.95(10.28) 
[(Diap)2Au(pn)2]Cl 170-3 30.01(29.98) 5.94(6.29) 17.04(17.48) 10.42(10.00) 
[(Imt)Au(N,N'-Me-en)]Cl 190-1 19.83(19.89) 4.65(4.29) 12.88(13.25) 8.17(7.59) 
[(Diaz)2 Au(N,N'-Me-en)]Cl3 Dcmps.>250 23.09(23.10) 5.04(4.52) 12.91(13.47) 10.20(10.28) 
[(Diap)2 Au(N,N'-Me-
 
Dcmps.>250 25.85(25.79) 5.37(4.95) 12.31(12.89) 8.99(9.84) 
[(Imt)Au(N,N'-iPr2-en)]Cl 260-2 27.80(27.59) 6.05(5.47) 11.85(11.70) 7.16(6.70) 
[(Diaz)2Au(N,N'-iPr2-en)]Cl3 238-9 29.01(28.26) 5.84(5.34) 12.87(12.36) 8.99(9.43) 
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3.6.3 KAu(CN)4 complex preparation 
Gold(III)-tetracyanide was prepared according to literature [16]. Two solutions 
were prepared separately; solution 1 consists of 2.00 g (5.33 mmol) auric acid 
dissolved in 5 mL distilled water, and solution 2, 1.73 g KCN (8% K13C15N 
enriched) (26.62 mmol) dissolved in 5 mL distilled water. Solutions 1 and 2 were 
mixed while stirring (this reaction must be done in fume hood, since HCN gas will 
evolve from reaction vessel), a white precipitate was formed immediately, and 
when allowed to grow for 3 hours, produced a solid, which was separated by 
decantation and dried in open air area, 95 % yield was obtained. IR data showed 
υ(CN-) band at 2189 cm-1 corresponding to [Au(CN)4]- that agrees with literature 
data [16]. 
3.6.4 KAu(CN)4 reaction with phosphines 
KAu(CN)4 (~0.6 mmol) was dissolved in 15 mL acetone. Ligand (~ 1.2 mmol) was 
dissolved in 20 mL absolute ethanol, the two solutions were mixed in round 
bottom flask and refluxed for ~3 hours at 75 oC. The resulting solution was filtered 
and concentrated. Product was crystallized out from solution. Elemental analysis 
and melting point data for the synthesized complexes are given in table 3.4. 
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Table 3.4: Elemental analysis and melting point of the synthesized complexes.  
 
 
 
Found (Calc.) %  
Complex m. pt. (oC) C H N S 
[((2-CN-Et)3P)2Au(CN)] 205-6 38.65(38.44) 4.05(3.97) 15.91(16.09)  
[(Cy3P)2AuCN].KCN 137-8 53.87(53.76) 7.55(7.84) 3.45(3.30)  
[(Me3PS)2Au(CN)3] Dcmps. 22.56(22.00) 3.70(3.69) 8.87(8.55) 12.59(13.05) 
[(Et3PS)3Au(CN)3] 94-6 34.19(34.76) 6.30(6.25) 5.61(5.79) 13.14(13.25) 
[(Ph3PS)2Au(CN)3] 160-1 54.65(54.23) 3.65(3.51) 4.62(4.87) 7.23(7.42) 
[(Me3PSe)2Au(CN)3] 150-2 18.14(18.47) 3.09(3.11) 6.97(7.18)  
[(Ph3PSe)Au(CN)3].KCN 181-3 38.06(38.77) 2.20(2.22) 8.03(8.22)  
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3.7. Computational study  
3.7.1    [Au(alkyldiamine)Cl2]Cl complexes. 
Geometry optimization was done for the built structures and optimized by Density 
Funactional Theory (DFT) level of theory with LanL2DZ (Los Alamos ECP plus 
double-zeta) [66,67] basis sets using Gaussian 03W program package [68]. 
3.7.2 [(His)Au(en)]Cl3 complex. 
Geometry optimization was done for the built structures and optimized by DFT 
(B3LYP) level of theory using GAUSSIAN03 program package [68] with the 
following basis set; SDD  for the gold, 6-31G(d) for the carbon, oxygen, nitrogen, 
and hydrogen. The optimized geometry was confirmed as minimum by running 
vibrational frequency on the optimized geometry using the same basis set.  
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CHAPTER FOUR 
RESULTS AND DISCUSSION 
4.1 Synthesis and characterization of gold(III) complexes with unsubstituted, 
N-mono and N,N'-di-substituted alkyldiamine ligands. 
4.1.1 Electronic spectra 
The λmax values for the complexes studies are given in table 4.1.  Au(III) 
complexes show absorption in the region 250-350 nm (40,000-28,570 cm-1) which 
correspond to LMCT transitions signal at ~300 nm that could be assigned to 
Cl→Au charge transfer by analogy to auric acid absorption spectra which give a 
band at 320 nm [69], where this transition of extinction coefficient can't be 
assigned to the symmetry forbidden d-d transition. According to crystal field theory 
for d8 complexes the LUMO orbital is dx2-y2, so ligand to metal charge transfer 
could be due to pσ→dx2-y2 transition [70].  Six-membered ring complex shows the 
lowest wavelength absorption at 293.5 nm which indicate the relative stability of 
the six member ring over both five and seven member rings. However, substitution 
on alkyldiamine nitrogen increased the absorption wavelength > 300 nm. This is 
consistent with a destabilizing steric effect caused by the substituents as the 
complexes under study. 
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Table 4.1 : UV-Vis spectra λmax for Au(III) complexes of alkyldiamine. 
Complex λmax (nm) 
HAuCl4 320.0 
1a 297.0 
1b 293.5 
1c 296.0 
3a 307.0 
3b 308.5 
3c 311.5 
3d 301.0 
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4.1.2 Infrared spectroscopy 
 
Infrared spectra of the complexes (Table 4.3) show a shift to higher 
wavenumber of N-H stretching band compared to free ligand in the range of 200 
cm-1. This could be a result of the absence of hydrogen bond after complexation 
because the nitrogen electron’s pairs are involved in Au-N bond. The C-N 
stretching bands also showed a slight shift to higher wavenumber indicating a 
shorter C-N bond in the complex than for the free ligand.  
Assignments of the vibrational bands are based on the computationally 
obtained frequencies at the B3LYP level with LanL2DZ bases set.  
Far-IR showed signals at 353 to 367 cm-1 for symmetric and asymmetric 
stretching of the Au-Cl, which is consistent with Au-Cl stretching mode trans to 
nitrogen [71,72], and another group of bands at 391 to 491 cm-1 for the symmetric 
and asymmetric stretching of the Au-N bond [73a].  The red shift of the 
alkyldiamine complexes with respect to the auric acid shows the weakening of the 
Au-Cl bond.  The Au-N stretching bands of the six and seven member metalcycle 
gold(III) complexes shows higher wavenumber than five member ones, indicating 
the higher stability for the six and seven member metalacycle complexes with less 
strained bonds.  
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Table 4.2.   IR frequencies, ν(cm-1) Au(III)-alkanediamine complexes 
 
Complex υ(N-H) υshift υ(C-N) υshift 
en 3393 w  1033 m  
1a 3422 br 29 1045 m 12 
pn 3357 m, 3282 m  1093 w  
1b 3447 br 90 1178 s 85 
bn 3356 br, 3290 br  1069 m  
1c 3422 m, 3330 w 66, 40 1148 m 79 
N-Me-en 3282 w  1130 m  
2a 3424 br 142 1047 m -83 
N-Et-en 3276 br  1130 m  
2b 3612 w, 3537  w 336 1197 m 67 
N-iPr-en 3300 m, 3289 m  1174 m  
2c 3484 br 184 1122 m -52 
N-2-hydroxyl-Et-en 3280 br  1123 w, 1051 m  
2d 3424 br 144 1160 w 37 
N,N'-Me2-en 3288 br  1148 w,1103 m  
3a 3407 w 119 1172 w 24 
N,N'-Et2-en 3235 br  1125 s  
3b 3563 w, 3371 w 328 1111 w -14 
N,N'-iPr2-en 3249 br  1173 m  
3c 3525m, 3421m 276 1115 m -58 
N,N'-(2-hydroxy-Et)2-en 3263 br  1058 m  
3d 3400 s, 3313 s 137 1066 s 8 
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Table 4.3: Far-IR data for 1a, 1b, and 1c complexes 
Species Au-Cl Au-N 
HAuCl4 367 - 
1a 353, 367 391,474 
1b 358 491 
1c 355 457, 499 
 
Table 4.4:  13C NMR chemical shifts of free ligands and Au(III)-alkanediamine 
complexes in D2O. 
 
0BSpecies C-1 C-2 C-3 C-4 
en 37.32    
1a 51.75    
pn 37.61 25.79   
1b 39.81 27.70   
bn 39.78 24.77   
1c 47.21 27.51 24.76 39.81 
N-Me-en 36.26 46.37 34.18  
2a 48.93 61.83 42.45  
N-Et-en 36.41 44.40 44.37 11.42 
2b 50.21 57.49 49.23 12.89 
N-iPr-en 36.58 42.27 52.58 19.07 
2c 49.91 56.70 52.19 20.14 
N-hydroxy-Et-en 57.48 50.64 44.99 36.41 
2d 58.38 57.73 56.03 49.90 
N,N'-Me2-en 45.15 34.20   
3a 58.90 46.29   
N,N'-Et2-en 44.36 43.24 11.25  
3b 56.83 51.14 11.52  
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Table 4.4 shows the assignments of the various 13C NMR resonances of 
ligands and complexes.  
13C NMR downfield shift was observed for complexes with respect to the  free 
diamine ligands. This can be attributed to the σ-donation of nitrogen lone pair to 
the gold ion that causes de-shielding of the carbon(s) next to the bonding nitrogen.  
The shifts vary significantly from one ligand to another suggesting different 
degrees of σ-donation from the ligand to the metal (Table 4.4).  For example, in 
the series 1a,1b and 1c (Scheme 1.1) as the complex ring size was changed, six-
membered ring 1b shows least chemical shift difference, indicating least 
participation of the propylenediamine ligand carbons in the electron donation to 
the metal.  Another observation is that 13C NMR spectra of 1a and 1b show the 
same number of signals compared to free ligand, while butylenediamine complex 
(1c) shows four different carbon atom resonances, instead of two in the free 
ligand.  This could be attributed to the 7-membered ring adopting a puckered 
conformation where the equivalence of the carbons is lost, probably due to the 
ring folding  away from the [AuN2] plane and the slow fluxional rate of the ring is 
on the NMR time scale.  
 
In the complexes 2a, 2b, 2c and 2d (Scheme 1.2) C-1, C-2 and C-3 signals in 
the 13C NMR (Table 4.4) show considerable chemical shift difference relative to 
the corresponding free ligand.  Comparison of ligand and complex chemical shifts 
reveal that the C-2 is the most de-shielded atom while in complex 2d the largest 
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effect was on C-3. Another observation is the down field shift of C-3, this effect 
decreases with increasing the substituents volume as we go from methyl (8 ppm 
for 2a)  to isopropyl (< 1 ppm in 2c), this means less involvement of C-3 in the 
bonding as observed for bulkier groups. 
N,N'-di-substituted complexes of gold(III) are shown in Scheme 1.3, 13C NMR 
shows two resonances for both carbons C-1 and C-2 next to nitrogen, suggesting 
symmetry of the two substituents with respect to each other, but this does not 
differentiate whether there two groups are cis or trans with respect to the complex 
plane. 
1H NMR for gold(III) complexes of alkyldiamine ligands showed very 
complicated spectra because of the strained structure and inequivalency of the 
hydrogen environments in the complexes.  
Recently, Silve et al [73b] studied four new ligands derived from 1,3-
propanediamine with different carbon chains lengths in an attempt to correlate this 
factor, which influences the lipophilicity of the compounds, with cytotoxic activity. 
The effect of the four complexes on the growth of two tumoral cell lines, and their 
cellular uptake were investigated.  They reported that lipophilicity enhances the 
rate of cellular uptake and, consequently, the cytotoxic activity.  In this study, we 
have also prepared several new complexes with different carbon chains.  It will be 
of interest to study their cytotoxic activity in comparison with cis-Pt complex. 
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4.1.3 Solid-State NMR 
At the spinning speeds employed in our experiments, we observe only the 
isotropic signals due to the carbons and nitrogens, with small anisotropies due to 
the sp3 hybridizations of these atoms. Compared to solution chemical shifts, slight 
de-shielding in solid state is observed. Similar to solution NMR, four signals of 
carbon atoms appear for the complex [Au(bn)Cl2]Cl (1c), this supports the idea of 
the unequivalency of the four carbon atoms of the butylenediamine. The 15N NMR 
for complexes 1a, 1b and 1c were also measured and presented in Table 4.5.  
Comparison of the shift for free ligand with bound, suggest the nitrogen atoms of 
the ethylenediamine complex were least affected by complexation while these of 
butylenediamine were the most affected. This is consisitent with the largest 
electron donation being for the butylenediamine ligand to the gold (III) ion.  This 
could be interpreted by the steric strain in five-membered ring in ethylenediamine 
complex.  The strength of lone pair donation from N atom to the gold(III) increases 
in the order en < pn < bn in consistence with Far-IR data. 
Recently Messori et al. described the in vitro activity of a series of gold(III) 
complexes, [Au(en)2]Cl3, [Au(dien)Cl]Cl2, [Au(cyclam)](ClO4)Cl2, [Au(terpy)Cl]Cl2, 
and [Au(phen)Cl2]Cl, against the A2780 ovarian cancer cell line and a cis-platin 
resistant variant [74,75]. The relative order of cytoxicity was Au(terpy) >> 
Au(phen) > Au(en), Au(dien) >> Au(cyclam).  Interestingly the three most active 
compounds retained activity against the cis-platin-resistant cell line.
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Table 4.5: Solid-state 13C and 15N-NMR Isotropic Chemical Shifts (δiso). 
Complex 15N C-1 C-2 C-3 C-4 
en•HCl (solid) -342.68     
1a -342.09 53.76    
pn•HCl (solid) -343.12     
1b -337.86 43.19 27.36   
bn•HCl (solid) -343.36     
1c -333.23 51.24 26.30 27.66 41.73 
2a - 46.58 63.74 37.36  
2b - 46.29 58.62 41.54 15.42 
2c -  50.56 - 21.54 
2d - 59.98 53.28 47.94 38.04 
3a - 62.89 45.13 33.38 15.14 
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In this study, we have demonstrated that the chemical shift difference 
between free and bound ligand for the solid 15N NMR decreases as bn > pn > en, 
indicating stronger Au-N bond for bn complex compared to pn and en.  The UV-
Vis studies show relative stability of the Au(III) complexes of unsubstituted 
ethylenediamine with respect to their N,N'-di-substituted analoges.  It will be of 
interest to test these three complexes for their anti-cancer activity and compare 
them with cis-Pt complex.   
4.1.4 Computational study 
                   
         a                                       b                                             c 
Scheme 4.1: Optimized geometries of 4.1a, 4.1b and 4.1c, obtained at the 
B3LYP/LanL2DZ level of theory using Gaussian 03W, revision B04. 
B3LYP optimized structure was analyzed computationally for NMR spectra 
using B3LYP/LanL2DZ level of theory which shows acceptable error from the 
experimental values from the crystal structure of the gold(III) complex with 
ethylenediamine [5].  Selected bond lengths bond and torsion angles of the 
computationally optimized structure are presented in tables 4.6 and 4.7, 
respectively.  
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Table 4.6: Selected bond lengths for [Au(alkyldiamine)Cl2]Cl for optimized 
structure using B3LYP\LanL2DZ. 
 4a 4b 4c 
Au-N(1) 2.133 2.129 2.135 
Au-Cl(1) 2.379 2.389 2.392 
Au-N(2) 2.133 2.129 2.131 
Au-Cl(2) 2.379 2.389 2.391 
 
Table 4.7: Selected bond and torsion Angles (°) for [Au(alkyldiamine)Cl2]Cl for 
optimized structure using B3LYP/LanL2DZ. 
 4a 4b 4c 
N(1)-Au-Cl(1) 91.34 86.30 85.49 
N(1)-Au-Cl(2) 175.04 179.37 179.09 
Cl(1)-Au-Cl(2) 93.60 94.01 93.71 
N(2)-Au-Cl(1) 175.04 179.17 179.03 
N(2)-Au-Cl(2) 91.34 85.88 85.38 
N(1)-Au-N(2) 83.72 93.80 95.43 
N(2)-Au-N(1)-C(1) 13.97 40.66 67.74 
Cl(1)-Au-N(1)-C(1) -165.56 -138.52 112.59 
Cl(2)-Au-N(1)-C(1) 18.76 -19.46 84.25 
Au-N(1)-C(1)-C(2) -39.45 -57.54 56.80 
N(1)-Au-N(2)-C(2) 13.84 -40.66 82.24 
Cl(1)-Au-N(2)-C(2) 19.27 56.39 -117.34 
Cl(2)-Au-N(2)-C(2) -165.75 138.79 -97.33 
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4.2 Investigation of the interaction of gold(III)-alkyldiamine complexes with 
L-histidine and imidazole ligands. 
1H NMR spectrum was studied and en-H signal was monitored in the free ligand 
and [Au(en)Cl2]+ complex at different pD’s.  Chemical shift of both en as free 
ligand and as [Au(en)Cl2]+ complex were directly increased in the range pD 1 to 2 
as a result of en-nitrogen protonation.  However, minor change of chemical shift 
was observed with pD in the range 2.0 to 6.0 (Figure 4.1).  At pD higher than 
alkyldiamine pKa value (7.0) [Au(en)Cl2]+ complex was found to be very stable 
because of better donation to the Au(III) metal center. 
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Figure 4.1: 1H NMR chemical shift of free en (●) and en in [Au(en)Cl2]+ complex 
(■) as function of pD. 
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Figure 4.2:1H NMR spectra of L-histidine reaction with [Au(en)Cl2]+ vs. time at pD 
1.6. (a) L-Histidine before mixing (pD=1.6), (b) 1hour after mixing (i) represents 
free L-histidine., (ii) represents L-histidine bound to Au(III) , (iii) represents en 
bound to Au(III) and (iv) represents free en (c) 4 hours after mixing and (d) 50 
hours after mixing. 
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Spectrum of free L-histidine in solution at pD =1.6 is shown in Figure 4.2A.  
Signals at ~ 8.58, 7.20, 4.05 and 3.42 ppm (Figure 4.2) coresspond to position 6, 
5, 2 and 3 protons of L-histidine, respectively.  Study of 1H NMR spectra of L-
histidine vs. time (Figure 4.2) shows continuous intensity increase of signals 
corresponding to [(His)Au(en)]3+ complex in solution (signal (ii)) along with 
decrease of signals correspond to free L-histidine. This shows that L-histidine and 
[Au(en)Cl2]+ reaction starts in solution right after mixing, while L-histidine oxidation 
products could be distinguished in by 1H NMR in ~ 1 hour. L-histidine oxidation 
leads to the formation of  2-oxy-histidine and 2-hydroxy-histidine in equilibrium 
(Scheme 4.3) as shown by Zhao et al [76] along with gold(III) reduction which 
deposited on glass as Au(0).   
 
Scheme 4.2: L-Histidine atom numbering. 
 
Scheme 4.3: 2-oxy and 2-hydroxy-histidine equilibrium. 
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Table 4.8: 1H NMR chemical shifts of [Au(en)Cl2]+ complex with L-histidine and 
imidazole ligands at various pD’s in aqueous solution. 
 en / [(His)Au(en)]3+ 
 
 His / [(His)Au(en)]3+ Others 
pD H-en  H6 H5 H2 H3 HO-His. 
1.6 3.22/3.11  8.56/ 8.58 7.31/7.20 4.21/ 3.89 3.32/ 3.49  8.06 
2.5 3.22/ 3.12  8.56/8.59 7.28/7.19 3.98/3.75 3.24/ 3.21 8.07 
3.9 3.20/ 3.11  8.23/ 8.50  7.23/ 7.20 3.88/3.69 3.19/ 3.40 8.23 
 en/[(Imi)2Au(en)]Cl3  Imi / [(Imi)2Au(en)]Cl3  
 H-en  H1 H2   HO-Imi. 
5.0  3.22 / 3.11  8.54/ 8.15 7.33/ 7.22   8.30 
6.5 3.08/ 2.94  8.48/7.99, 8.04 7.24/ 7.07, 6.98    8.29 
His. atom numbering refers to scheme 4.2. 
Imi. atom numbering refers to scheme 4.12. 
 
Table 4.9: 13C NMR chemical shifts of the [Au(en)Cl2]+ complexes with L-histidine 
ligand at pD’s 1.6 and 2.8. 
    His / [(His)Au(en)]3+   Others 
 pD C-en C1 C2 C3 C4 C5 C6  
en / [Au(en)Cl2]+  37.30 / 51.77        
His. 1.6 - 171.22 52.84 25.89 127.34 11910 135.24  
[(His)Au(en)]3+ 1.6 51.80 177.02 51.82 28.75 127.30 117.29 137.14  
His. 2.8 - 173.13 54.21 26.49 128.10 118.60 134.83  
[(His)Au(en)]3+ 2.8 51.93 176.91 53.80 29.24 127.41 117.16 138.87 146.7, 151.0 
His. atoms numbering refers to Scheme 4.2. 
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L-Histidine oxidation products such as 2-oxy-histidine and 2-hydroxy-
histidine were detected by NMR. The 1H signal at ~8.2 ppm corresponds to 2-
hydroxy-histidine.  The 13C NMR, where signals at 151 and 146 ppm correspond 
to 2-oxy-hisidine and 2-hydroxy-histidine, respectively. 
L-Histidine oxidation was carried out  by hydrogen peroxide and the 1H 
NMR spectra showed the formation of 2-hydroxy-histidine (δ = 8.2 ppm).  The H5 
and H6 signals were shifted downfield after oxidation due to the deshielding effect 
of oxygen. However, histidine reaction with gold complex shows upfield shift of H5 
and downfield shift of H6, indication of ligation to metal through N3. Time 
dependent monitoring of signal at 8.2 ppm, correspond to 2-hydroxy-histidine, 
shows that redox reaction became more significant within ~ 4 hours (Figure 4.2C).   
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Figure 4.3: 1H NMR monitoring of L-histidine-H5 signal intensity vs. time. (▼) 
refers to free L-histidine and (●)  refer s to [(His)Au(en)]3+ complex at 25 
oC and pD = 1.6. 
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Figure 4.3 shows time dependant integration of signals corresponding to 
free L-histidine molecules and that bound to Au(III) metal ion in solution.  Free and 
reacted L-histidine signals show decay in solution after ~ 200 min.  This decay 
could be the result of L-histidine oxidation, which is consistent with the 
appearance of 2-hydroxy-histidine signal at 8.2 ppm (Figure 4.2). 
Signal corresponding to en in the complex [(His)Au(en)]3+ couldn’t be 
followed by 1H NMR because of overlapped resonances (region from 3.1 to 3.3 
ppm). Sharp decay of 1H NMR signal (ii) corresponds to en ligand bound to Au(III) 
(Figure 4.2) was observed along with increase of the en in solution (signal iv, 
Figure 4.2B-D).   
Figure 4.4 shows released en ligand concentration vs. time, which was 
found to be linear through out the reaction time.  Ligand (en) release could be an 
indication of the gold(III) reduction or en ligand exchange by L-histidine in solution.  
However gold(III) reduction seems to be more plausable, which is consistent with 
metallic gold deposition.  
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Figure 4.4: Intensity (a.u.) of the en-H 1H NMR signal for L-histidine reaction with 
[Au(en)Cl2]+ complex vs. time. (●) Refers to en-H in [Au(en)Cl2]+ and  (▼) 
refers to en-H as free ligand at 25 oC and pD = 1.6.  
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Figure 4.5: Intensity (a.u.) of the L-histidine-H3 1H NMR signal in [(His)Au(en)]3+ 
vs. time for L-histidine reaction with [Au(en)Cl2]+ at pD 1.6 (●) and 3.9 
(□). 
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L-Histidine has three pKa's 1.82 (carboxylic acid), 6.04 (pyrrole NH) and 
9.17 (ammonium NH) [77] hence 1H NMR experiments were run at pD’s ranges 
from 1.6 to 10.4.  H3 signal (atom numbering refers to Scheme 4.2) was 
monitored and presented in Figure 4.5, which corresponds to [(His)Au(en)]3+ 
formation in solution vs. time at pDs 1.6 and 3.9.  It was found that L-histidine 
reaction rate with [Au(en)Cl2]+ complex was directly proportional to solution pD.  At 
pD’s 6.0 and 10.4 reactions were very fast and direct change of colour were 
observed immediately after mixing.  1H NMR showed a remarkable increase of the 
signal corresponding to 2-HO-histidine, so we could conclude that immediate 
redox reaction takes place at high pDs.  2-HO-histidine signal change was 
monitored by 1H NMR. A higher rate at pD 10.4 was found compared to pD’s 6.5 
and 3.9. The higher OH- ion concentration in solution likely that promotes histidine 
oxidation. 
L-Histidine has four expected binding sites; carboxylate-O, amine-N and 
two imidazole-Ns.  Appleton et al [78] have studied the interaction of histidine with 
platinum(II) and palladium(II) complexes with diethylenetriamine (dien) ligand, 
which acts as a tri-dentate ligand leaving one available binding site.  They have 
reported that carboxylate binding is thermodynamically unstable while amine-N 
binding is also not very stable, but it could presumably form pseudo-chelate 
binding with imidazole (Scheme 4.4). However, deprotonated imidazole-N binding 
was reported as thermodynamically preferred at pH 7.0.   
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Scheme 4.4: [(Dien)M(His)]2+, where M = Pt or Pd. 
 
Zhu et al [5] have studied the interaction of ethylendiamine-gold(III) 
complex with guanosine 5'-monophosphate (5'-GMP). They concluded that 5′ -
GMP is bound to [Au(en)Cl2]+  by chelating through N(7) – O(6) or through N(7) – 
phosphate (Scheme 4.5) and that Au(III) undergoes hydrolysis reaction at pD > 
2.5-3.0, and this report confirms the binding through oxygen at gold(III) 
complexes. 
 
Scheme 4.5: 5'-Guanosine Mono Phosphate. 
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Table 4.9 shows 13C NMR chemical shifts of free and Au(III) bound L-
histidinein the presence of [Au(en)Cl2]+ complex in solutions at pD’s 1.6 and 2.8.  
Higher change of chemical shift are observed at pD 2.8, this could be due to 
deprotonation of L-histidine carboxylic group so more electrons will be available 
for binding through carboxyl group.  The signal corresponding to C1 in L-histidine 
shows the highest change in chemical shift (~ 5 ppm) at both pD’s, because it has 
the lowest pKa value. At pD 1.6, evidence of carboxylate-O binding of  L-histidine 
C1 comes from the down-field shift of C1 signal (atoms numbering refers to 
scheme 4.2), while up-field shift of C5 signal and downfield shift of C6 signal minor 
up-field shift of C4 signal are indication of binding through imidazole ring.  As pD is 
raised to 2.8, L-histidine structure will be in equilibrium (Scheme 4.6).   
 
 
Scheme 4.6: L-Histidine pH dependant structure. 
Similar shifts were observed at pD = 2.8 by 13C NMR  for [(His)Au(en)]Cl3 
complex as mentioned before at pD = 1.6 (Table 4.9) but with less shift for C1 
signal indicating that legation through carboxylate group decreases, which could 
behave as counter ion rather than coordinationally binding ligand. C1 signal 
decreases within a periods of 4 days indicating histidine distribution into several 
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distinct species in solution and signals at 151 ppm and 146 ppm corresponding to 
2-oxy and 2-hydroxy-histidine appear, respectively.  
 
Our results have shown that gold(III) metal could be encapsulated by L-
histidine by legation of imidazole-N and amine-N as well as carboxylate group that 
exchange the chloride counter ion in the presence of chelating en ligand.  This 
mode of binding may illustrate the gold(III) histidine affinity (Scheme 4.7A), which 
has been reported by Iori et al [79] who have studied L-histidine-gold(III) 
interaction computationally, and concluded that imidazole side chain of histidine 
amino acid binds to Au(III) covalently through deprotonated imidazole, which they 
have reported as responsible for protein gold affinity. 
          
 
(A)                                                             (B) 
Scheme 4.7: (A) Suggested [(His)Au(en)]3+ structure and (B) [(His)Au(en)]3+ 
structure optimized computationally at the B3LYP/SDD level of theory 
using GAUSSIAN03 W, Revision B.04. 
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Table 4.10: Selected bond lengths (Å) and bond angles (o) for [(His)Au(en)]3+ for 
optimized structure using B3LYP/SDD. 
 Bond distances (Å) 
Au-O 2.883 
Au-N1 2.125 
Au-N3 2.057 
Au-N(en)trans-N3 2.116 
Au-N(en)trans-N1 2.110 
 Bond angles (o) 
O-Au-N1 61.52 
O-Au-N3 112.56 
O-Au-N(en)trans-N3 66.43 
O-Au-N(en) trans-N1 116.04 
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Prefered L-histidine ligation site was reported to be through N2 or N3 of the 
imidazole ring [78] (for atoms numbering refer to Scheme 4.2), at pD > 6.0, while 
carboxylate-O and amine-N binding were reported at low pH [78].  However, we 
are suggesting  the binding to be initially through N3 (Scheme 4.7A) at low pD as 
evidenced by 1H and 13C NMR spectra, where de-shielding of C6 and shielding of 
C5 were observed for imidazole ring. This is followed by amine-N1 binding in a 
chelating mode, while the carboxylate group acts as a third binding site in a 
distorted square pyramid structure. The same structure was also obtained after 
computational optimization of the L-histidine interaction with [Au(en)Cl2]Cl 
(Scheme 4.7B) in which carboxyl group rearrange itself at the top of the square 
planar structure in a distorted square pyramidal shape.  This chelating mode, in 
addition to carboxylate presence as counter ion, stabilizes this structure as well as 
enhances the oxidation of imidazole ring and decarboxylation reaction of L-
histidine by gold(III) complex to produce histamine.  Positive charge at the 
imidazole ring can stimulate the imidazole oxidation by enhancing nucleophilic 
attack at C6 carbon. This illustrates oxidation preference at C6 and also the 
increased rate of gold reduction by L-histidine at elevated solution pHs.  Decay of 
C1 signal may be a result of histidine decarboxylation reaction by [Au(en)Cl2]+ 
complex, which produces CO2 and histamine (Scheme 4.8), this suggestion is 
supported by previous reports about metal catalyzed decarboxylation of amino 
acids, particularly histidine [80,81].   
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Scheme 4.8: L-Histidine decarboxylation. 
 
To study the effect of the length of the chelating ligand, alkyldiamines of 
different length such as en, pn and bn (Scheme 4.9) have been used.   
 
Scheme 4.9: pn and bn atoms numbering. 
Table 4.11 shows the change of chemical shift of Au(III)-pn and bn 
complexes (Scheme 4.10) upon reaction with L-histidine. Comparable change of 
L-histidine chemical shift were observed upon reaction with both Au(III)-pn and 
Au(III)-bn complexes. 
 
Scheme 4.10: [(His)Au(alkyldiamine)]3+. 
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Table 4.11: 1H NMR chemical shifts of the complexes and ligands of  Au(III)-pn 
and Au(III)-bn complexes with L-histidine at pD ≈ 3.0. 
 H1a-pn H2a-pn H6c H5 H2 H3 HO-His 
Pn 3.106 2.051      
 [Au(pn)Cl2]+ 2.912  2.098      
 His / [(His)Au(pn)]3+ 3.281  3.249 8.688/ 8.722 7.420/ 7.323  4.190/ 4.495 3.387/ 3.914 8.116 
 H1b-bn H2b-bn      
bn 3.044 1.754      
[Au(bn)Cl2]+ 3.097 1.854      
His / [(His)Au(bn)]3+ 3.303 3.270 8.695/ 8.727 7.431/ 7.332 4.247/ 4.497 3.418/ 3.974 8.226 
a. pn atoms numbering refers to scheme 4.9A. 
b. bn atoms numbering refers to scheme 4.9B. 
c.  His. atoms numbering refers to scheme 4.2. 
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Figure 4.6: Intensity (a.u.) of L-histidine-H5 1H NMR signal in 
[(His)Au(alkyldiamine)]3+ vs. time for L-histidine reaction with 
[Au(en)Cl2]+, [Au(pn)Cl2]+ and [Au(bn)Cl2]+ at 25 oC and pD ≈ 3.0. 
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Time dependant spectra of binding of Au(III)-en, Au(III)-pn and Au(III)-bn 
with L-histidine were studied. Monitoring of reacted L-histidine-H5, figure 4.6 
shows faster reaction for larger metallacycle ring size.  No significant electronic 
difference is expected for en, pn and bn ligands, but ligands can be arranged 
according to ligand chain length as bn > pn > en, so faster reaction were with 
longer chain ligands. This conclusion is supported by Combariza et al [82]. They 
reported that in solution, when chelating ring size increase from five to seven a 
substantial increase of stability in gas phase is observed. However in solution a 
poorer metal-ligand overlap takes place as ligand size increases. 
Gold(III) complexes with  several imidazole derivatives were prepared and 
found to have a square planar structure [83].  Reaction of [Au(en)Cl2]Cl with 
imidazole was carried out at three different pD’s, 1.5, 5.0  and 6.5. 1H NMR 
chemical shifts are shown in table 4.8.  No reaction was observed at pD 1.5, the 
reactivity increases at pD 5.0, while even faster reaction was observed at pD 6.5.  
at pD = 6.5 > imidazole pKa (6.00), so the pyrrole nitrogen is more deprotonated, 
so mere electron density is available for donation so it binds stronger (Scheme 
4.11). 
 
Scheme 4.11: [(Imi)2Au(en)]3+. 
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Time dependent UV-Vis absorption intensity (at 305 nm) of [Au(en)Cl2]+ 
complex reaction with L-histidine at pH = 2.9 was measured (Figure 4.7). L-
Histidine showed a slope of 1.11 at constant Au(III)-complex concentration (Table 
4.12) while Au(III)-complex showed a slope of 1.14 at constant L-histidine 
concentration (Table 4.13).   
Data are shown in tables 4.12 and 4.13 along with calculated k′ at pH = 2.9 
and both components show first order rate equation.  Hence the rate expression 
for the reaction is 
Rate=k[Au-complex] [His][H+]X 
At constant pH, the rate equation becomes   
Rate=k′[Au-complex] [His] 
Where k′ = k [H+]X 
Similar systems were not found in literature in which rate constant was 
measured, however, kobs was reported to be 110 M-1.s-1 for HAuCl4 reaction with 
histidine by Soni et al [84] that is three times faster than [Au(en)Cl2]+ reaction with 
histidine.  The difference in kobs could be a result of trans effect caused by en 
ligand, but the difference in trans directing of en and chloride is not crucial [85], 
however, the reason could be the availability of more exchangeable chloride 
ligands in HAuCl4 than in [Au(en)Cl2]+ complex where one side is blocked by en 
ligand. 
 
Scheme 4.12: Imidazole atoms numbering 
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Figure 4.7:  (A) log (initial rate) vs. log [His] in solution ranging from 0.5 to 2.0 mM 
at constant [Au(en)Cl2]+ concentration (1.0 mM). (B) log (initial rate) vs. 
log ([Au(en)Cl2]+) ranging from 0.5 to 2.0 mM in solution at constant L-
histidine concentration (0.5 mM). All solutions were prepared using 
0.01M phosphate buffer at pH = 2.9. 
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Table 4.12: kinetic data for the absorption change of [Au(en)Cl2]+ complex at 
different L-histidine concentrations and constant [Au(en)Cl2]+ concentration 
of 1.0 mM at 25 oC and pH = 2.9. 
[His] mM Initial rate (ν) log [His] log (ν) k'(L•mol-1•s-1) 
0.50 2.08 x 10-5 -3.30 -4.68 41.6 
1.00 4.09 x 10-5 -3.00 -4.39 40.9 
1.50 5.30 x 10-5 -2.82 -4.28 35.3 
2.00 7.78 x 10-5 -2.70 -4.11 38.9 
 
Table 4.13: kinetic data for the UV absorption change of [Au(en)Cl2]+ complex at 
different [Au(en)Cl2]+  concentrations and constant L-histidine 
concentration of  1.0 mM at 25 oC and pH = 2.9.  
[Au(en)Cl2]+ (mM) Initial rate (ν) log ([Au(en)Cl2]+) log (ν) k'(L•mol-1•s-1) 
0.50 1.67 x 10-5 -3.30 -4.78 33.3 
1.00 4.09 x 10-5 -3.00 -4.39 40.9 
1.50 5.67 x 10-5 -2.82 -4.25 37.8 
2.00 8.00 x 10-5 -2.70 -4.10 40.0 
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4.3. [Au(en)Cl2]Cl interaction with L-methionine and DL-Seleno-methionone. 
4.3.1 [Au(en)Cl2]Cl interaction with L-methionine (Met). 
Met is an essential α-aminoacid classified as nonpolar, and together with L-
cysteine, constitute the two sulfur-containing proteinogenic amino acids [86]. It is 
also one of the most important bio-ligands that affect the efficacy of antitumor 
complexes [57]. Interaction of Met with cis-platin (cis-[(NH3)2PtCl2]) was studied by 
El-Khateeb et al [26].  They reported that Met binds to cis-platin first by hydrolysis, 
then the chloride ligand is exchanged by H2O, which is later exchanged by Met-S 
ligation, then it rearranges to N, S chelate complex. Thioethers, as in thiols, are 
oxidized into sulphoxide forms by gold complexes. This was found to be the 
source of their toxicity [57]. 
We are here reporting the interaction of Met with Au(III) with one side 
blocked by the chelating en ligand. 
Table 4.14 shows 1H NMR chemical shifts data for Met reaction with 
[Au(en)Cl2]+ and HAuCl4.  Significant de-shielding was observed of Met protons 
upon reaction, H4 and H5 resonances show the largest down-field change in 
chemical shift indicating bonding through sulfur. After 18 hours, ~ 86 % of en 
ligand has dissociated from [Au(en)Cl2]+.   
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Table 4.14: 1H NMR chemical shifts for Met interaction with [Au(en)Cl2]+ in D2O at 
25 oC, pD = 3.8. 
 en H5 H4 H3 H2 
Met   1.987 2.486 1.960 3.724 
Met + [Au(en) Cl2]+ 3.115 2.375 2.706, 2.602 2.196 3.829 
Met + HAuCl4 - 2.552 2.225 2.932, 2.875 4.080 
 
Table 4.15: 13C NMR chemical shifts of Met reaction with [Au(en)Cl2]+ in D2O at 
25 oC, pD = 3.8. 
 en C1 C2 C3 C4 C5 
Met - 174.97 54.64 30.44 29.62 14.73 
[(Met)Au(en)]3+ 51.65 173.69 53.65 32.52 49.95 24.40 
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Figure 4.8: 13C NMR spectra of (a) free Met-13C5  while spectra (b) to (e) are for 
Met-13C5 after reaction with [Au(en)Cl2]+, (b) after 17 min, (c) after 34 min, (d) after 
44 min, and (e) after 7 hours, in D2O at 25 oC, pD = 3.8. 
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Figure 4.8 shows 13C NMR spectra for Met-13C5 reaction with [Au(en)Cl2]+, 
signal at 14 ppm, which is due to 13C5 disappeared and three signals appeared in 
the spectrum, 17 min after mixing (Figure 4.8b), corresponding to three different 
forms of Met in solution. The signals at 23, 33 and 37 ppm are assigned to Au(III)-
Met, [(Met-S,N)Au(en)]Cl3 and Met-SO-CH3, respectively.  
Several experiments were carried out by reacting Met with H2O2 and 
HAuCl4.  These experiments are intended to confirm our assignments.  
The signal at 23 ppm corresponding to [(Met-S)Au(en)]3+, was decreasing 
until it completely disappeared after 1 hour.  The signal at 33 ppm also decreased 
and the signal at 37 ppm became dominant after 7 hours. This indicates a 
complete oxidation of Met to Met-SO-CH3 along with Au(III) reduction into Au(I). 
The chemical shift assignments are shown in Table 4.15. 
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Table 4.15 shows the release en ligand from [Au(en)Cl2]+ complex after 
reaction. An experiment, where Met 13C-labeled at C5 is oxidized by H2O2, was 
carried out. It resulted in the disappearance of the signal at 15 ppm and the 
appearance of two signals corresponding to C5 that represents oxidation products 
of Met.   
13C NMR Met-13C5 oxidation by H2O2, signal at 37 ppm was formed after 
reaction that correspond to Met-SO-CH3, while signal at 23 and 33 ppm were not 
found indication that these signals correspond to Met-gold complexes.    
 Figure 4.9 shows 1H NMR spectra for Met reaction with HAuCl4, the 
reaction was carried out at pD = 3.8 that higher pH will cause the hydrolysis of 
[Au(en)Cl2]Cl complex [5]. Down field shift of H5, H3 and H2 is observed after 
coordination ion to gold. The multiplet signal corresponds to C3 as shown for Se-
Met reaction with NaAuCl4 by Isab [87].  Polymeric [Au(Met)]n complex 
precipitated out of solution after few days.   
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Figure 4.9: 1H NMR spectra of (a) Met, spectra (b) after mixing with HAuCl4 (white 
ppt formed in solution), (c) after Na2S2O3 added to solution (d) after 10 days in 
D2O at 25 oC, pD = 3.8. 
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Figure 4.10: 13C NMR spectra of (a) Met, spectra (b) after mixing with HAuCl4 
(white ppt formed in solution and clear solution decanted) (c) after Na2S2O3 added 
to solution, in D2O at 25 oC, pD = 3.8. 
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Figure 4.10 shows 13C NMR spectra for Met that are recorded before and 
long period of time after reaction with HAuCl4 (2 day). Figure 4.10b shows a signal 
at 37 ppm attributed to Met-SO-CH3 indication of Met oxidation by gold(III) that is 
reduced to gold(I). Polymeric [Au(Met)Cl]n was precipitated out of solution, and 
when Na2S2O3 was added to the solution, reduction of Met-SO-CH3 took place. 
The reactions could be described by equations (1) and (2). 
        Vujačić et al [88] have studied Met reaction with HAuCl4 that shows that Met 
binding on Au(III) metal center takes place via exchange of one chloride ligand 
and then rearrangment into chelating Met-S,N binding. These results are 
consistent with our finding i.e. the formation of three species of Met that convert 
finally into Met-SO-CH3. We propose that [Au(en)Cl2]+ reacts with Met according to 
equation_(3). 
 From the preceeding discussion we may suggest that the reaction 
proceeds through the following reaction mechanism (Equations 4 to 7). 
The reaction starts with [Au(en)Cl2]+ hydrolysis, as expected by comparison with 
reaction with cis-platin complex, as  shown by El-Khateeb et al [26]. One Cl- ligand 
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is exchanged by Met-S ligand that rearranges into chelating mode of Met-S,N 
(Equation 5).  The reduction of Met takes place in the next stage concurrent with 
en ligand dissociation and gold(I) formed in solution (Equation 6). The reaction 
stops finally by the precipitation of Au(I) with non-oxidized Met as polymeric 
[Au(Met)Cl]n. 
4.3.2 [Au(en)Cl2]Cl interaction with DL-Seleno-methionine (Se-Met). 
Selenium compounds have received more attention in the recent decades and 
found to be an essential element in mammals [89]. It is known that seleno-ligands 
binds more strongly to gold complexes than thio-ligands [51,90]. DL-Seleno-
methionine (Se-Met) interaction with [Au(en)Cl2]+ was studied in this work and 13C 
NMR was recorded for the reaction. Reaction of [Au(en)Cl2]+ with Se-Met was 
carried out using Se-Met labeled 13C5. The 13C NMR spectrum was recorded for 
the resulting solution (Figure 4.11). Fast and complete shift of signal at δ = 4 ppm, 
corresponding to C5, to 32 and 34 ppm, that are attributed to [(Se-Met)Au(en)]3+ 
(C5΄ signal) and Met-SeO-CH3 (C5˝ signal), respectively. These signals were 
assigned by comparison with spectrum resulting from Se-Met-13C5 oxidation 
experiment by H2O2. The mechanism suggested for Met is also applicable for Se-
Met. Hence the reaction mechanism could be described as chloride ligand 
exchange by Se-Met followed by Se-Met oxidation while gold(III) is reduced into 
gold(I) along with en ligand dissociation from the reduced gold(III) metal center 
and the precipitation of white polymeric [Au(Se-Met)Cl]n. 
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Figure 4.11: 13C NMR spectra for Se-Met-13C5 before reaction (a) and after 
reaction with [Au(en)Cl2]+ at 1:1 ratio (b), in D2O at 25 oC and pD = 3.7. 
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4.4 [Au(en)Cl2]Cl interaction with thiols 
4.4.1  [Au(en)Cl2]+ interaction with L-cysteine 
L-Cysteine is an α-amino acid with the chemical formula HO2CCH(NH2)CH2SH, it 
is classified as a non essential hydrophilic amino acid. Because of the high 
reactivity of this thiol, L-cysteine is an important structural and functional 
component of many proteins and enzymes. Cystine is its oxidized dimer (Scheme 
4.13) [91]. 
L-Cysteine has pKa values 1.92 for -COOH, 10.46 for –NH3+ and 8.35 for –
SH side chain [77] and considered as S- and N- donor nucleophile [92]. Cysteine 
and penicillamine (Scheme 4.15) generally, form similar complexes with transition 
metal ions with subtle difference in some redox reactions [93]. Most thiols such as 
L-cysteine and thiomalic acid reduce gold(III) to gold(I) and form stable complex 
[93]. Penicillamine was reported to form a stable complex with gold(III) ion if 
present in excess but will reduce it to gold(I) if present in 1:1 ratio [93].  
                                
(a)                                                           (b) 
Scheme 4.13:  (a) L-Cysteine  and (b) L-Cystine. 
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In the present work, interaction of L-cysteine and penicillamine ligands with 
[Au(en)Cl2]+ complex in aqueous solution were studied by 1H and 13C NMR 
spectroscopy. 
L-Cysteine reaction with [Au(en)Cl2]+ at 1:1 ratio was carried out and 1H 
NMR chemical shifts were recorded and presented in table 4.16. The reaction pD 
was adjusted to 3.7 before mixing. At acidic pD only the carboxylate group will be 
ionized, nevertheless 1H NMR chemicals shifts of L-cysteine show down-field 
change in chemical shifts of H2 and H3 signals as shown by table 4.16. Reaction 
monitoring by 1H NMR shows en ligand dissociation from complex, and after 14 
hours a complete release of en ligand (signal at 3.222 ppm) is observed.  
However, 1H NMR is not much informative according to complex oxidation state. 
When the pD of the reaction mixture was adjusted to 7, immediate dissociation of 
en ligand from the complex was observed by 1H NMR. This could be a result of 
hydrolysis of the complex as shown by Zhu et al [5]. 
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Table 4.16: 1H NMR chemical shifts of [Au(en)Cl2]+ complex with L-cysteine in 
D2O at 25 oC, pD = 3.7. 
 Free en / en in complex H2 H3 
[Au(en)Cl2]+ - / 3.093 - - 
CySH - 4.176 2.966, 2.945 
[Au(en)Cl2]+ + CySH 3.222 / 3.087 4.252 3.277, 3.134 
* Atoms numbering refer to Scheme 4.13(a) 
 
Table 4.17: 1H NMR chemical shifts of [Au(en)Cl2]+ complex with D-penicillamine, 
pD = 3.7 in D2O at 25 oC. 
 free en / Au(III)-en H2 H4 
PaSH  3.610 1.414, 1.334 
[Au(en)Cl2]+ + PaSH 3.192 / 3.089 3.821 1.712, 1.620 
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Figure 4.12: (a) 13C NMR spectra for L-cysteine before and (b) after reaction with 
H2O2, while (c) and (d) are 13C-DEPT NMR spectra after reaction with H2O2 at 1:1 
ratio and when excess H2O2 reacted, respectively,  in D2O at 25 oC. 
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Figure 4.13: 13C NMR for (a) L-13C3-cysteine (b) 13 min after reaction with 
[Au(en)Cl2]+ and (c) 24 hours after mixing, at 1:1 ratio in D2O at 25 oC, pD = 3.7.  
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13C NMR spectra for L-cysteine before and after oxidation by H2O2 are 
shown in Figure 4.12, chemical shift assignments were made by 13C-DEPT NMR 
experiment (Figure 4.12c).  Figure 4.12d shows that when excess H2O2 is used, it 
reacted to form cystine, which was further oxidized into cystic acid as shown by 
Shaw et al [57]. 
Figure 4.13 shows 13C NMR spectra of labeled L-13C3-cysteine before and 
after reaction with [Au(en)Cl2]+ at 1:1 ratio in D2O at 3.7.  We observe the 
formation of a signal at 36 ppm corresponding to [(CyS)Au(en)]2+, this signal 
decays very fast and is converted to the signal at 38 ppm that correspond to 
cystine (Figure 4.13 (b)). The signal at 51.0 ppm also gradually increased. This 
was assigned to cysteic acid. Ethylenediamine ligand dissociation from the 
complex is observed, which is a good indication of Au(III) reduction.  
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Figure 4.14 13C NMR spectra of 13C3 labeled L-cysteine reaction with [Au(en)Cl2]+ 
(a) L-cysteine, (b) 30 min, (c) ~11 hours and (d) ~ 24 hours, at 2:1 ratio in D2O at 
25 oC, pD = 3.7. (atom numbering refers to scheme 4.13a) 
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A reaction was also carried out at 2:1 ratio of L-cysteine : Au(III) (Figure 
4.14). We observe in these spectra that L-cystine is formed faster, i.e. complete 
conversion after 30 min, (Figure 4.14b). The signal corresponding to 
[(CyS)Au(en)]2+ was not found in this spectrum. This could be a result of a fast 
reaction, in which two Cl- ligands are exchanged fast by L-cysteine followed by 
reductive elimination of L-cystine along with Au(III) reduction into Au(I) and en 
ligand dissociation. After standing 24 hours (Figure 4.14 d), L-cystine was 
completely oxidized into cystic acid (δ = 51.0 ppm) as shown earlier for cystine 
oxidation by Shaw et al [57]. 
Scheme 4.14: L-Cysteine reaction mechanism with [Au(en)Cl2]+. 
We propate that the reaction of L-cysteine with [Au(en)Cl2]+ complex goes 
into three main steps as shown by scheme 4.14. First the exchange reaction of 
chloride ligand by L-cysteine takes place so C3 signal shifted down-field to 36 
ppm. Then L-cysteine oxidation and Au(III) reduction into Au(I) occur so intensity 
of C3 signal at 36 ppm decreases gradually and L-cystine signal appear at 38 
ppm. The later is oxidized to cystic acid (signal at 51 ppm). The signal 
corresponding to [Au(en)Cl2]+ did not vanish completely, indicating the catalytic 
behavior of this complex.   
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4.4.2 [Au(en)Cl2]+ interaction with D-penicillamine 
D-Penicillamine is a pharmaceutical of the chelator class. It is a metabolite of 
penicillin, although it has no antibiotic properties [95], D-penicillamine interaction 
with gold is a very important interaction in rheumatoid disease treatment as shown 
by Pritchard et al [96]. 
                                                                                        
                                    (a)                                              (b) 
Scheme 4.15: (a) D-Penicillamine and (b) D-Penicillamine dimer. 
Figure 4.15 shows 1H NMR spectra for D-penicillamine before and after 
reaction with [Au(en)Cl2]+, correspond to free en ligand, at 3.19 ppm, and in 
[Au(en)Cl2]+ complex, at 3.08 ppm, are shown in spectra (b) and (c). Free en 
signal was found to increase at the same rate as decreasing [Au(en)Cl2]+ signal. 
Chemical shifts for this reaction are given in table 4.17 . 
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Figure 4.15: 1H NMR spectra for D-penicillamine, (a) before mixing (b) 10 min 
after reaction and (c) 2 hours after reaction with [Au(en)Cl2]+, in D2O at 25 oC. 
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Figure 4.16: 13C NMR spectra for D-penicillamine (a) before reaction, (b) after 
reaction with H2O2 (c)13C-DEPT spectrum after reaction with H2O2, in D2O at 25 
oC. 
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Figure 4.17: 13C NMR spectra for (50 mM) D-penicillamine (a) before reaction, (b) 
3 hours after reaction  and (c) 6 hours after reaction with [Au(en)Cl2]+, reactant 
mixed at 1:1 ratio in D2O  at 25 oC, pD = 3.7. 
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13C NMR chemical shifts assignment for D-penicillamine after oxidation were done 
by oxidizing D-penicillamine using H2O2 solution. The disappearance of the signal 
at ~50 ppm in 13C DEPT NMR spectrum (Figure 4.16(c)) indicates that it 
corresponds to D-penicillamine-C3.  
Signals corresponding to D-penicillamine C1, C2 and C4 were found to be 
shifted up-field upon reaction, while C3 was found to shift down field due to 
electron donation through sulfur. 
Figure 4.17 shows 13C NMR spectra for D-penicillamine reaction with 
[Au(en)Cl2]+, the signal corresponding to [Au(en)Cl2]+ complex decreased 
gradually, while en ligand dissociation takes place, (signal at ~37 ppm). After 6 
hours ~ 80 % of [Au(en)Cl2] complex released its en ligand, as measured by 1H 
NMR spectroscopy.  
 
Scheme 4.16: [(Pa-S,N)Au(en)]3+ structure 
This reaction could be summarized as follows: D-penicillamine exchanges 
a chloride ligand from [Au(en)Cl2]+ complex, (Scheme 4.16). This is followed by D-
penicillamine oxidation into the di-sulfide, while Au(III) reduced into Au(I), along 
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with en ligand release from the complex. No signals were observed that 
correspond to penicillamine dimer as found for cysteine, which could be hindered 
by steric factor of the bulky penicillamine ligand.  
4.4.3 [Au(en)Cl2]Cl interaction with Captopril 
Captopril is an angiotensin-converting enzyme inhibitor used for the treatment of 
hypertension and some types of congestive heart failure [97]. It is present in two 
conformers cis and trans (Scheme 4.17) both forms are present in solution with 
dominancy according to solution pH [98,99]. Rabenstein et al [100] reported that 
trans conformer is dominant at low pH, while both conforms will be present as pH 
raised. 
 
(A)                                                   (B) 
Scheme 4.17: (A) trans-  and (B) cis- captopril. 
Captopril consists of 3-mercapto-2-methyl propanal and the proline 
moieties which behave differently in solution and have distinct signals in NMR.  
Captopril was reported to have pKa for carboxylate 3.7 and 9.8 for the thiol group 
[101].  
In this work we studied captopril interaction with [Au(en)Cl2]+ at ~ pD = 3.6 
and monitored by NMR techniques. 
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Interaction studies of [Au(en)Cl2]+ complex with captopril were performed 
by mixing D2O solutions of 140 mM at 1:1 ratio at pH 3.5.  Immediate change of 
color to yellow and then to milky was observed right after mixing, indicating a fast 
reaction.  
 
Scheme 4.18: Captopril atoms numbering. 
1H NMR spectra showed up-field shift to captopril-Hα (at 4.3 ppm), while H3 
signal (at 2.8 ppm) was shifted but could not be distinguished after reaction, 
indication of immediate reaction through sulfur. 
 
13C DEPT NMR spectra were recorded for captopril reaction with H2O2, 
which were used for signals assignment. Figure 4.18(b) shows 13C DEPT NMR 
spectrum before oxidation and (c) shows spectrum after oxidation by H2O2. C2 
was found to be shifted up-field while C3 and Cα show down-field shift after 
oxidation by H2O2.  
Figure 4.19 show 13C NMR spectra for captopril before and after reaction 
with [Au(en)Cl2]+, en ligand signal showed complete dissociation from metal 
center, while we can observe very high down-field shift of signal corresponding to 
C3. This could be a result of captopril being bound to gold(III), as assigned using 
13C DEPT NMR. Chemical shifts were assigned as shown in table 4.18. 
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Figure 4.18: 13C NMR spectra for captopril (a) before, (b) 13C DEPT NMR before 
reaction with H2O2 and (c) 13C DEPT NMR spectrum after reaction with H2O2, in 
D2O at 25 oC and pD was 3.0. 
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Figure 4.19: (a) 13C NMR spectra for captopril before reaction and (b) after 
reaction with [Au(en)Cl2]+, in D2O at 25 oC and pD = 3.5.  
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Table 4.18: 13C NMR chemical shifts of [Au(en)Cl2]+ complex reaction with 
captopril in D2O at and 25 oC, pD = 3.5. 
 en CO2 Cα Cβ Cγ Cδ CON C3 C2 C1 
cis-Captopril   - 60.61 31.66 22.97 47.76 177.87 - 43.27 17.23 
trans-Captopril   177.14 60.06 29.85 25.25 48.71 177.56 27.50 42.60 16.85 
Captopril + [Au(en)Cl2]+ 37.33 176.91 60.14 29.85 25.23 48.62 178.36 54.68 34.59 17.52 
 
Table 4.19: 1H NMR chemical shifts of [Au(en)Cl2]+ reaction with thiomalic acid in 
D2O at 25 oC, pD = 3.7. 
 en H3 H2 
TmSH - 3.634 2.808, 2.768 
[(TmS)2Au(en)] 3+ 3.106 3.800 2.926, 2.820 
 
Table 4.20: 13C NMR chemical shifts of [Au(en)Cl2]+ complex reaction with 
thiomalic acid in D2O at and 25 oC, pD = 3.7. 
 en C=O C4 C3 C2 
TmSH  177.55 175.62 40.17 36.72 
TmSH + [Au(en)Cl2] + 37.31 174.96 175.19 36.41 48.46,48.14 
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Table 4.18 shows 13C NMR chemical shifts for cis and trans conformers at 
pH 3.5 before and after reaction with [Au(en)Cl2]+.  Immediate dissociation of en 
ligand from metal center takes place. This is an indication of Au(III) reduction into 
Au(I), which accompanies generally captopril oxidation into the di-sulfide form. 
However the later was not detected after completion of the reaction. C3 signal 
shows change in chemical shift to 54.68 ppm that is assigned to [(Cap-S)2Au]+.  
This down-field shift of C3 is concurrent with the up-field shift of C2 signal by 8 
ppm. That could be an indication of binding through oxygen at C1 and Sulfur.  
Corresponding spectra are shown in Figure 4.19.  Similar mechanism for captopril 
could be suggested for other thiols. 
 
4.4.4 [Au(en)Cl2]+ interaction with Thiomalic acid 
Gold thiomalic acid complexes are used mainly for their anti-inflammatory 
action in the treatment of rheumatoid arthritis [57]. Interaction of thiomalic acid 
with [Au(en)Cl2]+ is presented.  
            
(a)                                                      (b) 
Scheme 4.19: (a) Thiomalic-acid and (b) Thiomalic-acid dimer. 
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Figure 4.20 : 13C NMR of thiomalic acid (a) before and (b) after reaction with H2O2 
in D2O at 25 oC. 
 
 
 
Figure 4.21: 13C NMR of thiomalic acid (a) before and (b) after reaction with 
[Au(en)Cl2]+ at 1:1 ratio, in D2O at 25 oC, pD = 3.7. 
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1H NMR chemical shifts for thiomalic acid before and after interaction with 
[Au(en)Cl2]+ are given in table 4.19. As expected, a downfield change in chemical 
shifts for both H2 and H3 signals is obserevd, with larger down-field shift for H3. 
This is an indication of a reaction through sulfur.  
 Thiomalic acid (TmSH) was oxidized by H2O2. 13C NMR spectra are shown 
in figure 4.20, C2' signal shifted down-field to 48 ppm, while C3' shows up-field 
shift after dimerization to 36 ppm. C1 and C4 also shows up-field shift after 
dimerization. C2' was the most affected by this reaction.     
 13C NMR spectrum of the species resulting from the reaction of thiomalic 
acid and [Au(en)Cl2]+ is shown in figure 4.21. This shows similar changes of 
chemical shifts as shown in the H2O2 experiment (Figure 4.20). The main reaction 
occur after mixing the components at 1:1 ratio is the thiomalic acid oxidation that 
produces the disulfide dimer, while Au(III) is reduced into Au(I) that causes the 
release of en ligand. Chemical shift assignments are given in table 4.20. C2 signal 
shows ~14 ppm downfield shift, while C3 signal shifted up-field by ~ 4 ppm after 
reaction. The signal corresponding to free en ligand in solution appears at 37 ppm 
right after mixing.  
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4.4.5 [Au(en)Cl2]Cl interaction with L-glutathione 
Glutathione (GSH) is a tripeptide that contains an unusual peptide linkage 
between the amine group of L-cysteine and the carboxyl group of the glutamate 
side chain. Glutathione along with glutathione reductase enzyme work as an 
antioxidant in living cells [102].  Glutathione reduces any disulfide bond formed 
within cytoplasmic proteins to cysteine by donating electrons while being 
converted to glutathione disulfide (GSSG). Glutathione reductase then transforms 
GSSG back to GSH [102]. The ratio of reduced glutathione to oxidized glutathione 
within the cells is used as a measure of cellular toxicity [102]. 
Lewis et al [55] discussed the reaction of gold(I) with glutathione and 
reported bonding GS-Au interaction to be through sulfur. Gold(III) reduction by 
glutathione was reported as pH dependent [103]. 
 
Scheme 4.20: L-Glutathione atoms numbering. 
In this work we studied [Au(en)Cl2]+ interaction with glutathione by means 
of 1H and 13C NMR spectroscopy. A comparison of this reaction with oxidation by 
H2O2 (Figure 4.22) was performed.  
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1H NMR chemical shifts show minor changes upon reaction so they were 
not much informative in this reaction, except that en ligand can easily be 
monitored. It was found to dissociate from Au(III) complex over 13 hour. 
 Figure 4.22 shows 13C NMR spectra of L-glutathione oxidation by H2O2 
solution. The signal at 27 ppm corresponding to C3 was found to decrease while 
C3' signal assigned for GSSG was found to increase (at 39 ppm). C2 signal also 
shifted up-field upon L-glutathione dimerization. Figure 4.22 (b) shows signal after 
oxidation of  L-glutathione, So C3 and C2 signals shifted to C3' and C2', 
respectively. Figure 4.22 (c) shows the resulting spectrum after L-glutathione 
reaction with [Au(en)Cl2]+. In this spectrum we observed the dissociation of en 
ligand and the GSSG formation, after 10 hours of reaction. A brown precipitate 
also formed in solution after gold(III) reduction into metallic gold.   
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Figure 4.22: 13C NMR of glutathione, (a) before, (b) after oxidation by H2O2 and 
(c) after 6 hours of L-glutathione reaction with [Au(en)Cl2]+ at 1 to1 
ratio, in D2O solution at 25 oC and pD = 3.7.  
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Table 4.21: 13C NMR chemical shifts of [Au(en)Cl2]+ complex reaction with 
glutathione in D2O at 25 oC, pD = 3.7.  
 en C=O C2 C6 C1 C4 C5 C3 
GSH  178.05, 
175.60, 
174.09, 
173.33 
56.49, 
56.34 
54.32 42.10 31.87 26.67 26.14 
GSH + [Au(en)Cl2]+ 51.78 176.13, 
174.97, 
173.89, 
173.77, 
172.41 
53.01 54.12  42.08 31.77 26.17 39.48 
GSH + [Au(en)Cl2]+ 
13 hour 
51.72, 
37.64 
175.06, 
173.61, 
172.22, 
172.04, 
170.94 
53.01 53.33 41.97 31.72,
32.18 
26.28,
26.06 
39.38,
49.82 
Atoms numbering refers to scheme 4.20. 
94 
 
 
13C NMR chemical shifts are given in table 4.21, down-field change of C3 
chemical shift was observed to 39 ppm. This is indication of bonding through 
sulfur. After 13 hours we observe a small up-field change in chemical shift of C6 
indication of bonding through -NH2. Carbonyl signal shows general up-field shift 
after reaction with [Au(en)Cl2]+ after 13 hours indication of reaction progress.  Four 
C=O signals appear in spectra which shows up-field change in chemical shift after 
mixing, up-field shift increases after 13 hours and a signal appears at 39 ppm 
corresponding to GSSG compound which is expected to form in solution. 
Therefor we suggest the reaction mechanism to take place first by chloride 
exchange reaction by L-glutathione at gold(III) metal ion through sulfur, followed 
by di-sulfide reductive elimination.  Au(III) is then reduced into Au(I).  Excess 
glutathione will cause Au(I) reduction into metallic gold but the reaction at 1:1 ratio 
causes L-glutathione binding to Au(I) and precipitation of [(GS)2Au]+. After 
standing, chelating likely occurs through amine group, so C6 signal is shifted up-
field. Ethylenediamine ligand found to be continuously dissociate from the 
[Au(en)Cl2]+ complex along with gold(III) reduction into gold(I). 
4.5 [Au(alkyldiamine)Cl2]Cl with ergothionene and thiones 
4.5.1[Au(en)Cl2]+  with ergothionene (ErS) 
L-Ergothionene (ErS) is a unique, naturally occurring antioxidant that is abundant 
in most plants and animals [104]. High concentration of ergothioneine is found in 
the red blood cells [104] and tissues including liver, kidney, the eye, seminal fluid, 
and erythrocytes [104]. ErS exists in a thiol (ErSH), thione (ErS) equilibrium, as 
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given in scheme 4.21.  Thione is found to be dominant in the solid state and at pH 
= 7 [104-106].  
 
A                                                B 
Scheme 4.21: Ergothionene thione - thiol isomerization 
Reaction of ergothionene with [Au(en)Cl2]+ was carried out and monitored 
by 1H and 13C NMR spectroscopy.  
 
Scheme 4.22: Ergothionene (ErS) atoms numbering. 
1H NMR chemical shift for ErSH before and after reaction with [Au(en)Cl2]+  
are given in Table 4.22. The down-field shift of H5 signal soon after reaction is an 
indication of high reactivity and conversion of ergothioneine into its thiol form.  The 
de-shielding of protons takes place because of the ring aromaticity in the thiol 
form.  
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Table 4.22: 1H NMR chemical shifts of ergothioneine upon reaction with 
[Au(en)Cl2]+ at 2:1 ratio in D2O at 25 oC and pD = 3.7. 
 [Au(en)Cl2]+/ free-en H5 H2 H7 H3 
ErSH - 6.672 4.031 3.141 3.186 
ErSH + [Au(en)Cl2]+ 3.141/ 3.214 7.212 3.915 3.166 3.374 
Atoms numbering according to scheme 4.22. 
 
Table 4.23: 13C NMR chemical shifts of ergothioneine upon reaction with 
[Au(en)Cl2]+ at 2:1 ratio in D2O and 25 oC, pD = 3.7. 
 en C1 C2 C3 C6 C5 C4 C7 
ErSH - 169.64 75.75 23.39 157.01 116.58 123.82 53.20 
ErSH + [Au(en)Cl2]+  
7 hours 
37.30 170.06 76.50 23.58 150.87 117.56, 118.55 125.7 53.14 
ErSH + [Au(en)Cl2]+  
3 days 
37.29 170.28 76.78 23.59 148.35 117.87, 118.62 127.17 53.19 
Atoms numbering according to scheme 4.22. 
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Figure 4.23: 13C NMR spectra for ergothioneine (a) before reaction, (b) after 
reaction with H2O2 and (c) 7 hours after reaction with [Au(en)Cl2]+ in D2O at 2:1 
ratio at 25 oC, pD = 3.7. 
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As shown by Figure 4.23(a) ergothionene at pD = 3.7 is present as thiol. 
Figure 4.23(b) stands for ergothioneine after oxidation by H2O2. By comparison 
with Figure 4.23 (a) we can observe up-field shift of C6 and C2 signals while C5 
shifted down-field. C6΄ shifted to 134 ppm after dimerization. 13C NMR spectrum of 
ergothioneine after reaction with [Au(en)Cl2]+ at 2:1 ratio is shown in Figure 
4.23(c).  In this figure we can observe an up-field shift of C6 by 6 ppm (δ = 151 
ppm) indicating legation through thiol group.  No signs were found for 
ergothioneine dimerization by comparison with H2O2 reaction discussed earlier. 
However after three days, the 13C NMR spectrum C6 is shifted to 148 ppm, 
indicating the Au(III) reduction into Au(I) as shown by Ahmad et al [104]. 
Ethylenediamine ligand was found to dissociate from the complex after 7 hours 
(Figure 4.23(c)) and this supports the hypothesis of Au(III) reduction to Au(I), as 
discussed previously.  13C NMR chemical shifts for reactants before and after 
reaction are given in table 4.23.  
The up-field shift of C6 after legation through sulfur to the metal center can 
be rationalized as due to the electron deficiency produced that promotes electron 
compensation from the surrounding nitrogens.  
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4.5.2 [Au(alkyldiamine)Cl2]Cl with thiones. 
Gold-thiones have found great interest in recent research due to potent gold sulfur 
interaction which found several medicinal applications [1,59]. Thione heterocyclic 
rings with various metal ions, have received much interest [48,107,108]. Myocrisin 
and solganol used for the treatment of rheumatoid arthritis are gold-sulfur 
compounds [60,61].  Considerable work has been carried out on thione complexes 
with gold(I) [63], very little is known about Au(III) complexes with thiones.  
Imidazolidine-2-thione and its derivative ligands were reacted with gold(III)-
alkyldiamine complexes in 2:1 mole ratio. This resulted in formation of several 
complexes that were characterized by  melting point and elemental analysis, while 
structural analysis were done by IR spectroscopy and 13C and 15N solid-state 
NMR. 
This work reports the synthesis of gold(III)-alkyldiamine reaction with 
imidazolidine-2-thione and its derivatives such as Imt, Diaz and Diap. 
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Table 4.24:   IR frequencies, ν(cm-1) of [Au(en)Cl2]Cl complex with Imt, Diaz and 
Diap. 
Complex υ(N-H), cm-1 υ(C=S), cm-1 -N-C=S Asym str 
Imt 3200 506 - 
[(Imt)2Au(en)]Cl3 3426 w 495 2052 
[(Imt)2Au(pn)]Cl3 3426 s 497 2017 
[(Imt)2Au(bn)]Cl3 3400 w 496 2026 
[(Imt)Au(N,N'-Me-en)]Cl 3462, 3141 495 - 
[(Imt)Au(N,N'-iPr2-en)]Cl 3431, 3184 493 2039 
Diaz 3166 516 - 
[[(Diaz)2Au(en)]Cl3 3423 w 518 2044 w 
[(Diaz)2Au(pn)]Cl3 3444 m 517 2015 
[(Diaz)2Au(bn)]Cl3 3413 sh 499 2010 
[(Diaz)2Au(N,N'-iPr2-en)]Cl3 3447 489 - 
[(Diaz)2 Au(N,N'-Me-en)]Cl3 3445 517 2043 
[(NN’-di-Et-Diaz)2Au(en)]Cl3 3428 m - - 
Diap 3224 527a - 
[(Diap)2Au(en)2]Cl  3418 m 505 2019 
[(Diap)2Au(pn)2]Cl 3428 m 519 2020 
[(Diap)Au(bn)]Cl 3403 sh 495 2013 
[(Diap)2 Au(N,N'-Me-en)]Cl3 - 489 - 
[(Diap)2Au(N,N-iPr2-en)]Cl3 - 491 - 
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IR frequencies for the prepared complexes were recorded in the range 
4000-400 cm-1 using KBr pellet, selected IR frequencies are given in Table 4.24, 
vibrational frequency for thione ligands υ(C=S) shows red shift upon complexation 
as a result of electron donation from sulfur to the metal center that promote π-
back donation to thione π* orbital, this causes weakening of the C-S bond. N-H 
vibrational frequency υ(N-H) were found to shift to higher wavenumber (blue shift) 
indication of N-H bond strengthening in complex compared to the free ligand as a 
result of electron donation form sulfur [109]. Stretching frequencies in the range 
2010-2052 cm-1 were also recorded for the prepared complexes corresponding to 
υ(-N-C=S) band as reported by Ray et al [110]. 
Solution NMR data were not found to be descriptive for complexes, 
because of lack of stability of complexes in solution.  So NMR measurements in 
the solid state were preformed. The chemical shifts found are given in table 4.25.  
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Table 4.25: Solid-state 13C Isotropic Chemical Shifts (δiso) and Principle Shielding 
Tensors (σxx)  of [Au(alkyldiamine)Cl2]Cl complexes with Imt, Diaz, 
and Diap ligands.  
Complex 
Nnd 
ucleus 
δiso σ11 σ22 σ33 Span Skew Other 
[(Imt)2Au(en)]Cl3 13C 155.41      46.78 
 15N -260.14, -335.83       
[(Imt)2Au(pn)]Cl3 13C 177.03 257 183 90 167 0.116 46.58 
 13C 154.90 221 163 81 139 0.175  
 15N -258.2       
[(Imt)2Au(bn)]Cl3 13C 176.93 252 193 86 167 0.289 46.29 
 15N -259.6       
[(Diaz)2Au(en)]Cl3 13C 166.74 241 186 73 168 0.351 42.70, 19.41 
 13C 149.37 223 143 82 141 -0.127  
 15N -357.60       
[(Diaz)2Au(pn)2]Cl3 13C 167.31      43.48, 19.50 
 15N -337.47       
[(Diaz)2Au(bn)]Cl3 13C 171.69 244 189 83 161 0.319 44.74, 27.46 
 15N -205.2       
[(Diap)2Au(en)2]Cl  13C 172.46 273 201 44 229 0.366 45.22, 27.66 
 15N -258.2, -333.5       
[(Diap)2Au(pn)2]Cl 13C 172.08 227 211 78 148 0.792 45.90, 27.75 
 15N -257.0, -263.9       
[(Diap)Au(bn)]Cl 13C       44.84, 26.78 
[(Diaz)2Au(N,N'-Me-en)]Cl3 13C 154.32 226 153 84 142 -0.035 51.62, 41.15, 
  
 
[(Diaz)2Au(N,N'-iPr2-en)]Cl3 13C 146.16 194 141 10
4 
90 -0.170 71.82, 61.34, 
51 44  41 15  
  
[(Diap)2 Au(N,N'-Me-en)]Cl3 13C 159.17 216 154 10
8 
108 -0.153 46.58, 28.53 
Isotropic shielding, σi = (σ11 + σ22 + σ33 )/3;  Δσ = σ33 – 0.5(σ11 + σ22); η  =  3( σ22 
- σ11 ) / 2Δσ; [2,73,74].   
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 4.6 [Au(alkyldiaimine)Cl2]+ interaction with Imt 
Interaction of [Au(en)Cl2]+ complex with  imidazolidine-2-thione (Imt) has been 
studied by 1H and 13C  NMR spectroscopy.  Reactants were mixed at (1:2) and 
(1:1) ratios in D2O at 25oC , pD= 3.7. After mixing at 2:1 ratio, very fast reaction 
was observed and the solution color changed turn from yellow into turbid orange. 
1H NMR chemical shifts showed fast dissociation of en ligand (signal at ~3.1 ppm 
decrease) from gold complex due to Imt exchange or due to gold(III) reduction. Imt 
signal shifted to 3.87 ppm. When the reaction was carried out at 1:1 ratio, en 
ligand signal showed signals for both free en at 3.20 ppm and for metal bound 
ligand, while Imt showed two distinct signals at 3.67 ppm corresponding to Au(III)-
Imt and a signal at 3.83 ppm corresponding to Imt-dimer.  
The reaction of [Au(en)Cl2]+ with Imt was carried out at 1:1 ratio and 
monitored with time using the peak at 3.08 ppm, which corresponds to the en in 
[Au(en)Cl2]+, after 10 hours this signal was vanished almost completely, so it 
required 36 min for 60 % of bond en ligand to dissociate, while the rest of the en 
required more than 10 hours to dissociate. 
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Table 4.26: 1H NMR Chemical shifts for Imt reaction with H2O2 and [Au(en)Cl2]+ 
complex in D2O at 25 oC and pD = 3.7.  
 en N-H H1 Imt-S-S-Imt 
Imt   3.532  
Imt + H2O2    3.898 
[Au(en)Cl2]+ + Imt 
1eq : 1eq 
3.084, 3.195 3.911 3.674 3.836 
[Au(en)Cl2]+ + Imt  
1eq : 2eq 
3.191 3.954 3.713 3.865 
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Figure 4.24: 1H NMR monitoring of en-H signal intensity (a.u) vs. time. (●) refer s 
to free en and (▼) refer s to [(Imt)2Au(en)]3+ complex at 25 oC, pD = 
3.7. 
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Figure 4.25: 1H NMR monitoring of Imt-H signal intensity (a.u) vs. time. (▼) refers 
to free Imt and (●) refer s to [(Imt)2Au(en)]3+ complex at 25 oC, pD = 
3.7. 
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Figure 4.26: 13C NMR spectra of  (a) Imt before reaction, (b to f) Imt after reaction 
with [Au(en)Cl2]+ and (g) after reaction with H2O2, at 25 oC. 
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Figure 4.26 (a) shows 13C spectrum of Imt. The reaction with [Au(en)Cl2]+ 
was monitored and spectra (b-f) were obtained. Imt ligand C2 shifted up-field 
indicating binding to Au(III) but after standing di-sulfide starts to form and Au(III) is 
reduced into Au(I). The signals were assigned by comparison with Imt oxidation 
experiment by H2O2 as shown by figure 4.26 g. C2 corresponding to Imt-di-sulfide 
(Imt-S-S-Imt) was found in solution (δ = 166 ppm).  Ethylenediamine ligand was 
found to be released from [Au(en)Cl2]+ complex after reaction indicating Au(III) 
reduction. We can therefore suggest that the reaction starts with Imt ligand binding 
to gold(III) which is reduced very fast into gold(I). This leads to en ligand 
dissociation from [Au(en)Cl2]+ complex, Imt is oxidized into Imt-S-S-Imt and the 
corresponding chemical shift appeared at 166 ppm. The signal corresponding to 
Imt-Au(I) was found at 179 ppm.  
4.7 Gold(III)-tetracyanide interactions with L-cysteine, glutathione, captopril, 
L-methionine and DL-Se-methionine. 
[Au(CN)4]- interaction with different thiols and thioethers were carried out by 
mixing reactants at different ratios, and reactions were monitored by NMR and 
UV-visible absorption techniques. Selected data that show reaction progress are 
presented here. Signals assignments were carried out based on literature 
[16,103]. 
4.7.1 L-Cysteine interaction with [Au(CN)4]- 
The reaction was carried out for CySH with [Au(CN)4]- at 1:1 ratio and monitored 
by 1H NMR. 1H NMR chemical shifts for CySH reaction with [Au(CN)4]- are given in 
table 4.27. Downfield shift of signals corresponding to H2 and H3 were observed 
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after reaction. H3 signal showed more downfield shift indicating binding through 
sulfur atom, but 1H NMR is not much informative about gold ion oxidation state 
and cyanide ligand binding mode.  CySH reaction with [Au(CN)4]- was montored 
by 13C NMR (Figure 4.27c),  CySH-13C3 signal shifted downfield (from δ = 25 ppm 
to δ = 38 ppm) indication of oxidation into L-cystine, while Au(III) were reduced to 
Au(I) i.e. [Au(CN)2]- (δ = 156 ppm) [41,103].  Triplet signal at 112 ppm was 
assigned to cyanogen that may be reductively eliminated from auricyanide as was 
suggested by Ettorre et al [42] for the reductive elimination of Br2 from 
[Au(CN)2Br2]-. It is observed here that the signal corresponding to cyanogen (δ = 
112 ppm) appears as a deceptive triplet due to fully labeled cyanogen which has a 
spin system of AA'XX'.  The large one bond 13C-13C coupling in the spin system 
provides a deceptive triplet [112-114].  
No intermediates were detected from reaction, so it is not possible to shed 
light on the reaction mechanism. So further experiments where CySH-13C3 were 
reacted with [Au(CN)4]- at 0.5:1 equivalents, 1:1 equivalents; and at 2:1 
equivalents, respectively, CySH-13C3 were used for better monitoring of reaction 
in the NMR time scale, UV spectrophotometry was also employed for reaction 
monitoring in this work.  
Table 4.27: 1H NMR chemical shifts of [Au(CN)4]- complex with CySH ligands at 
1:1 ratio in D2O at 25 oC, pD = 7.4. 
 H2 H3 
CySH 3.922 2.980, 2.904 
[Au(CN)4]- + CySH 4.045 3.295, 3.268  
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Figure 4.27: 13C NMR of spectra for (a) [Au(CN)4]- (b) CySH and (c) 30 hours after 
reaction with [Au(CN)4]- at 2:1 ratio in D2O at 25 oC, pD = 7.4. 
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Figure 4.28: 13C NMR spectra for [Au(CN)4]- reaction with CySH-13C3  at 1:0.5, (a) 
for CySH-13C3 before reaction (b) 16 hours after reaction and (c) 36 
hours after reaction, in D2O and 25 oC, pD = 7.4.  
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 Figure 4.28 presents 13C NMR spectra for [Au(CN)4]- reaction CySH at 
1:0.5 ratio in D2O at pD 7.4. A complete shift of C3 corresponding signal was 
observed right after mixing, which splits into four new signals. The signal at 33.0 
ppm corresponds to mono-substituted complex [(CyS)Au(CN)3]-. The signal at 
38.5 ppm is attributed to sulfenic acid [115].  These two signals are converted 
gradually to CyS-SCy (38.2 ppm) and L-cysteic acid (CySO3H) (35 ppm). L-cysteic 
acid chemical shift was found almost the same as reported by Shaw et al after 
referencing to dioxin [57]. After 4 days all species were converted into L-cysteic 
acid (35 ppm).  
Figure 4.29 shows CySH reaction with [Au(CN)4]- at 1:1 ratio.  CySH-C3 
signal shifted downfield from 25 ppm (Figure 4.29b) to 33 ppm (Figure 4.29c). This 
is a result of fast cyanide exchange by CySH. Three signals correspond to 
cyanide were found in the spectrum (Figure 4.29c), i.e. [Au(CN)4]- (δ = 104 ppm), 
[Au(CN)2]- (δ = 156 ppm) and [(CyS)Au(CN)3]- (δ = 115 ppm). It is observed that 
initially there is a decay of [Au(CN)4]- in solution and then an increase (Figure 
4.29c). 
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Figure 4.29: 13C NMR spectra for [Au(CN)4]- reaction with CySH-13C3  at 1:1, (a) 
for CySH-13C3 before reaction (b) 2 hours after reaction and (c) 24 
hour after reaction, in D2O and 25 oC, pD = 7.4.  
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Figure 4.30: UV absorbance for [Au(CN)4]- (0.1 mM) and CySH (0.2 mM) before 
and after reaction at 1:0.5 mole ratio, in the range 200-310 nm  at 25 
oC and pH = 7.4 (0.1M phosphate buffer).  
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Figure 4.30 shows the UV absorption spectra for [Au(CN)4]- reaction with 
CySH at 1:0.5 mole ratio (pH = 7.4). Absorption band at 228 nm (band I) 
corresponding to [(CyS)Au(CN)3]- increased to its maxima in 3 minutes and then 
started converting gradually into set III bands after 8 days, indicating that the 
reaction is mainly progressing through one cyanide ligand exchange that is 
followed by [Au(CN)2]- formation with very low formation of the second cyanide 
exchange procedure, as shown by the very small intensity signal at ~ 289 nm in 
figure 4.30 . 
Based on earlier discussion, the following mechanism (Scheme 4.23) can 
be suggested.  
 
 
Scheme 4.23: Suggested mechanism for [Au(CN)4]- reaction with CySH at 1:0.5 
and 1:1 mole ratio. 
The reaction starts with cyanide exchange by CySH (Scheme 4.23), the 
corresponding signal is shown as CyS-Au(III) UV absorption at 228 nm.  Bands at 
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250 and 289 nm, corresponding to the disubtitute product, were not intense this 
indicate that CyS-SCy produced by reductive elimination from two adjacent 
[(CyS)Au(CN)3]- species resulted in the formation of CyS-SCy and hexacyano-
diaurate (Scheme 4.23), which undergoes disproportionation reaction into 
[Au(CN)4]- and [Au(CN)2]- in solution. The corresponding 13C NMR signals appear 
at 104.6 and 156 ppm respectively. The increase of cyanide signal intensity at 
104.6 ppm (corresponding to [Au(CN)4]-) is an indication of the disproportionation 
mechanism occurrence, that could regenerate the [Au(CN)4]- in solution after its 
consumption during the initial step. 
Figure 4.31 shows UV absorption spectra for [Au(CN)4]- reaction with CySH 
at 1:1 ratio pH = 7.4. A faster reaction occurs compared at 1:0.5 ratio (Figure 
4.30). Bands from 204 to 240 nm were distinct after 4 hours, while mono- and di-
substitution corresponding bands are concurrently present in solution. So it can be 
concluded that the reaction proceeds through two subsequent cyanide exchange 
steps by CySH followed by reductive elimination when relatively higher CySH ratio 
is present in solution. 
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Figure 4.31: UV absorbance for [Au(CN)4]- (0.1 mM) and CySH (0.2 mM) before 
and after reaction at 1:1 mole ratio, at 25 oC and pH = 7.4 (0.1 M 
phosphate buffer).  
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Figure 4.32: 13C NMR spectra (a) for CySH-13C3, (b) after 14 hours of reaction 
with [Au(CN)4]- at 1:2 ratio, in D2O and 25 oC, pD = 7.4 and (c) after 
32 hours of reaction.  
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Figure 4.32 shows representative 13C NMR spectra for [Au(CN)4]- reaction 
with CySH at 1:2 ratio. It is noted that CyS-SCy formation was much faster when 
CySH mole ratio increased.  Five signals in the cyanide region were found in 
figure 4.32b that represent five different species in solution; [Au(CN)4]- (δ = 104 
ppm), [(CyS)Au(CN) 3]- (δ = 115 ppm), [(CyS)2Au(CN)2]- (δ = 124 ppm), NCCN (δ 
= 112 ppm) and [Au(CN)2]- (δ = 156 ppm). The spectra show the formation of 
cyanogen (δ = 112 ppm), [Au(CN)4]- reduction into [Au(CN)2]-, CySH oxidation into 
CyS-SCy and formation of [(CyS)2Au(CN)2]- in solution (Figure 4.32c).  
[Au(CN)4]- reaction with CySH was also carried out at 1:2 ratio and 
monitored by UV spectrophotometry, as shown in figure 4.33.  The first exchange 
of cyanide take place very fast so the band at 228 nm appears at the first minute 
of reaction time and then it is converted into bands at 250 and 289 nm in less than 
3 minutes, indication of very fast consecutive exchange reaction, that converted 
later, after 30 min into bands from 204 to 240 nm corresponding to reduced 
[Au(CN)2]- resulting from fast reduction reaction when increased CySH mole ratio 
found in solution. 
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Figure 4.33: UV absorbance for [Au(CN)4]- (0.1 mM) and CySH (0.2 mM) before 
and after reaction at 1:2 mole ratio, at 25 oC and pH= 7.4 (0.1 M 
phosphate buffer).  
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UV absorption study reveals that the reaction proceeds through two 
consecutive cyanide ligand exchanges that take place very fast. However, some 
stability is found for [(CyS)2Au(CN)2]- because of cis/trans isomerization. The 
complex ion in the cis form will go very fast into reductive elimination reaction of 
CyS-SCy, while gold(III) reduced to gold(I) in the form of [Au(CN)2]-.  Suggested 
mechanism is shown in scheme 4.24. 
 
Scheme 4.24:  Suggested mechanism for [Au(CN)4]- reaction with CySH at 1:2 
equivalents. 
It can be concluded that higher CySH mole ratio in reaction leads to fast 
exchange of two cyanide ligands that is followed by reductive elimination of CyS-
SCy from cis-[(CyS)2Au(CN)2]- and formation of [Au(CN)2]-.  
 
4.7.2 Glutathione (GSH) interaction with [Au(CN)4]- 
GSH interaction with [Au(CN)4]- has been studied in aqueous solution at pH 7.4 by 
Shaw and co-workers [16]. They reported that the formation of [(SG)Au(CN)3]-, 
and [(SG)2Au(CN)2]- species were detected by mass spectrometry. In this work, 
interaction of GSH with auricyanide was studied using 1H and 13C NMR to 
compare the mode of interaction with other thiols. 
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Figure 4.34 shows 13C NMR spectra of GSH before and after reaction with 
[Au(CN)4]-. The C5 signal shifted down-field from 27 to 39 ppm, while C4 signal 
shifted up-field, indicating the formation of GSSG, the corresponding signals are 
C4' and C5' respectively [16,41]. Cyanide signals appeared at 156 ppm 
corresponding to [Au(CN)2]- and at 112 ppm and 115 ppm corresponding to NC-
CN and [(GS)Au(CN)3]-, respectively.  
 
Scheme 4.25: Suggested mechanism for [Au(CN)4]- interaction with GSH in D2O 
and 25 oC. 
Scheme 4.25 shows a suggested mechanism that may account for GSH 
reaction with [Au(CN)4]-. The reaction starts with two cyanide exchange by GSH, 
cis/trans isomerization takes place next, and the cis-isomer will go further into 
disulfide dimer by reductive elimination. 
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Figure 4.34: 13C NMR of GSH (a) before and (b) after reaction with [Au(CN)4]- 
oxidation at 2:1 ratio in D2O at 25oC, pD = 7.4. 
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4.7.3 Captopril (Cap) interaction with [Au(CN)4]- 
Cap isomerizes in solution into cis and trans isomers. The ratio of these isomers 
depends mainly on solution pH [100a-c], however, at pH 7.4 both isomers exist 
with a higher concentration of trans isomer (~ 60 %) as reported by Rabenstein et 
al [100d]. Oxidation of cap by H2O2 was carried out, and the products were 
analyzed using 13C NMR. 
 Figure 4.35 shows 13C NMR spectra for cap oxidation by H2O2. C2 was 
found to be shifted up-field upon dimerization into di-sulfide while C3 and Cα show 
down-field shift after oxidation. 
13C NMR spectra for cap reaction with [Au(CN)4]- in the range (0 to 75 ppm) 
are given in figure 4.36. The C3 signal was found to shift according to the earlier 
mentioned mechanism and it was also dependent on the thiol ligand ratio in 
solution (Figure 4.36b). It was shifted down-field to 41.6 ppm corresponding to 
Cap-S-S-Cap (Figure 4.36c).  Three distinct cap species were found in solution 
according to spectrum (Figure 4.36c). They correspond to un-reacted cap 
(referred as C3), cap di-sulfide (referred as C3') and [(cap)Au(CN)3]- species 
(referred as C3''). Other signals corresponding to cis/trans cap isomers were also 
found.   
 
125 
 
 
 
Figure 4.35: 13C NMR spectra for (a) cap (b) cap DEPT spectrum and (c) DEPT 
spectrum after reaction with H2O2 in D2O at 25 oC and pD = 7.4. 
126 
 
 
 
 
Figure 4.36: 13C NMR (0-75 ppm) spectra (a) for 100 mM cap before reaction, (b) 
after reaction with [Au(CN)4]- at 1:1 ratio and (c) after reaction with 
[Au(CN)4]- at 0.5:1 ratio, in D2O at 25 oC and pD = 7.4.   
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Figure 4.37: 13C NMR (0-190 ppm) spectra (a) for 100 mM cap before reaction, 
(b) after reaction [Au(CN)4]- at 1:1 ratio, (c) and (d) after reaction with [Au(CN)4]- at 
0.5:1 ratio, in D2O at 25 oC and pD = 7.4.  
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Figure 4.36 shows 13C NMR for cap reaction with [Au(CN)4]- at 1:0.5 mole 
ratio.  Four cyanide signals were found in spectrum corresponding to [Au(CN)2]- (δ 
= 156 ppm), cyanogen (δ = 112 ppm) and (115, 120 ppm respectively)  to 
cis/trans-[(cap)Au(CN)3]-.  These results indicate similar reaction intermediates to 
other thiols described earlier. The reaction proceeds through two cyanide 
substitution by cap at higher cap/ Au(III) ratio, while mono-substitution reaction 
takes place followed by disproportionation at lower ratio as shown earlier for CySH 
reaction with [Au(CN)4]-. The observation of similar intermediates produced during 
CySH, cap and GSH reactions with [Au(CN)4]- at the similar mole ratio leads to the 
conclusion that similar reaction mechanisms may be found for all these reactions, 
with high dependence on species ratio. 
4.8 L-Methionine (Met) and DL-Se-Methionine (Se-Met) interactions with 
[Au(CN)4]- 
Met and Se-Met interactions with auricyanide were studied by mixing the reactants 
at different ratios. No change was observed at all ratios by both 1H and 13C NMR 
at pDs 7 and 12. The monitoring by NMR was continued for more than three days 
but no reaction was found to take place in solution. However, when Se-Met was 
mixed with auricyanide at 2:1 ratio and pD adjusted to 12 and stirred for three 
days, a little [Au(CN)4]- was reduced to [Au(CN)2]- while Se-Met was oxidized into 
Met-SeO [116-118].  Signals were assigned by comparison with Se-Met oxidation 
experiment with hydrogen peroxide [90,119,120]. Se-Met binding to gold metal 
center is expected to be through selenium or amine group as reported from 
computational work for methyl-seleno-cysteine by Shoeib et al [34]. 
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Figure 4.38: 13C NMR for (a) Se-Met-13C5 before and (b) after reaction with 
[Au(CN)4]-, in D2O at 25 oC and pD = 12.0. 
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Met was reported to be highly reactive with Au(III) ion [121], but it showed 
no reactivity toward auricyanide even after stirring for five days. So it can be 
concluded that cyanide ligand causes stabilization for Au(III) against reaction with 
Met and Se-Met [51].  Lack of reactivity of Met and Se-Met with [Au(CN)4]- 
complex could be rationalized in terms of the strong Au(III)-CN bond at pH 7.4. 
However, at high pH (~12), hydrolysis facilitates the with ligand exchange reaction 
as shown by El-Khateeb et al [26].  They studied the interaction of Met with cis-
platin (cis-[(NH3)2PtCl2]) and reported that Met binding to cis-platin complexes 
proceeds first by hydrolysis of the complexes followed by Met-S ligation. The 
carboxylate and amine groups enhanced the reaction by electrostatic stabilization 
of the metal ligand complex [122,123].  
 
4.9 Synthesis and characterization of aurocyanide and auricyanide 
complexes of phosphines, phosphine sulphides and phosphine selenides. 
All reactions were done by mixing KAu(CN)4 with L ligands at 1:2 ratios. Product 
chemical formula, melting point and elemental analysis are given in Table 3.4. IR 
and UV spectra were measured for all synthesized complexes, the results are as 
follows. All gold(III) complexes show at least one band corresponding to cyanide 
in the range 2179-2192 cm-1, this band was missing from all gold(I) complexes.  
a.  [((2-CN-Et)3P)2AuCN] 
IR spectrum shows CN stretching band at 2245 and 2240 cm-1 corresponding to 
the cyanide at (2-CN-Et)3P ligand, and the other band at 2136 cm-1 corresponding 
to CN stretching as reported earlier by Yangyuoru et al [16], which is characteristic 
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of the Au(I)-cyanide. UV spectrum shows absorption bands at 204-240 nm, 
characteristic for Au(I)-cyanide [16,41]. 
b. [(Cy3P)2AuCN].KCN  
IR spectrum shows a band at 2140 cm-1 that is characteristic for Au(I)-CN moiety 
in complex [124], and UV absorption spectrum shows absorption bands in the 
range of 204 to 240 nm corresponding to Au(I)-CN [5].  
c. [(Me3PS)2Au(CN)3] 
IR data show a stretching frequency for the cyanide group at 2186 that is 
characteristic for Au(III)-CN moiety in complex, and no distinct signals were found 
in UV. 
d. [(Et3PS)3Au(CN)3] 
IR vibration spectrum shows a band at 2186 cm-1 assigned to Au(III)-CN, and no 
distinct signals were found in UV.  
e. [(Ph3PS)2Au(CN)3] 
 IR spectrum showed cyanide stretching frequency at 2192 cm-1 that is 
characteristic of Au(III)-CN, and no distinct signals were found in UV. 
f. [(Me3PSe)2Au(CN)3] 
IR data show a CN stretching bands at 2179 cm-1, characteristic of Au(III)-CN, and 
no distinct signals were found in UV corresponding to Au(I)-CN. 
g. [(Ph3PSe)Au(CN)3].KCN 
IR data shows CN stretching band at 2189 cm-1 characteristic of CN bound to 
Au(III) as shown by Yangyuoru et al [16,41]. 
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Phosphine ligand reaction with [Au(CN)4]- results in formation of tri-coordinate 
complexes. Three coordinate complexes are common in literature for gold 
phopshine complexes as reported for [Au(PPh3)2Cl] complexes by Tiekink et al 
[125]. Several three-coordinate gold(I) phosphine complexes were also reported 
by Parish [126]. 
Table 4.30 shows the IR and Far-IR data of the synthesized complexes.  
KAu(CN)4 complex showed stretching band at 2189 cm-1 that correspond to 
stretching band of Au(III)-CN moiety [16,41],  while KAu(CN)2 IR spectrum shows 
stretching band at 2140 cm-1 [124,128,129]. The difference in cyanide IR 
stretching bands could be a result of more electron density in gold(I) complex that 
lead to more π–back donation to the cyanide ligand, this increase the occupation 
in the cyanide anti-bonding (π*) orbital’s,  weakening the CN bond. Less number 
of coordinating ligand in KAu(CN)2 will also increase the electron back donation 
from metal to ligand, so Au-C get shorter and C≡N get longer these conclusion is 
consistent with the IR and Far-IR bands for K[Au(CN)2], the reverse is true for 
K[Au(CN)4] complex. 
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Table 4.28:  Solid (KBr-disk) IR and (CsCl-disk) Far-IR data for Au(III) and Au(I)-
cyanide complexes with phosphines.  
Complex ν(C≡N), cm-1 ν(Au-C), cm-1 υ(P-S/P-Se), cm
-1 υ(P-S-Au/P-Se-Au), cm-1 
K[Au(CN)2] 2140 471* - - 
K[Au(CN)4] 2189 418 - - 
[((2-CN-Et)3P)2AuCN] 2245, 2240, 2136 437 - - 
[(Cy3P)2AuCN].KCN 2140 419 - - 
[(Me3PS)2Au(CN)3] 2186, 2171, 2148 413 565 557 
[(Et3PS)3Au(CN)3] 2186, 2144, 2064 419 537 536 
[(Ph3PS)2Au(CN)3] 2192 410 540 516 
[(Me3PSe)2Au(CN)3] 2179, 2144, 2066 411 562 516 
[(Ph3PSe)Au(CN)3].KCN 2189, 2143 419 562 561 
* As reported by  Bowmaker et al [127]. 
 
Table 4.29: 31P and 13C NMR chemical shifts of synthesized complexes in CD3OD 
at 25 oC.  
 L-Au-(CN), 
13C δ(C≡N) 
(ppm) 
L, 31P δ 
(ppm) 
L-Au-(CN),31P δ 
(ppm) 
KCN 163.60   
KAu(CN)2 152.21   
KAu(CN)4 103.47   
[((2-CN-Et)3P)2AuCN] 120.17, 120.05 -32.21 49.36 
[(Cy3P)2AuCN] 113.04 58.51 61.33, 60.50 
[(Me3PS)2Au(CN)3] - 33.68 33.75 
[(Et3PS)3Au(CN)3] 116.72 56.82 51.41 
[(Ph3PS)2Au(CN)3] 106.21 43.83 43.85 
[(Me3PSe)2Au(CN)3] - - 48.55 
[(Ph3PSe)Au(CN)3].KCN 117.91 35.89 35.89 
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Signals correspond to cyanide in IR and UV could be employed for the 
determination of gold atom oxidation state; cyanide ligand in gold(III) complexes 
shows at least one stretching band in the range 2192-2186 cm-1, while these band 
is absent from all gold(I) complexes. The cyanide signal in gold(I) complexes show 
stretching band at 2142-2136 cm-1, and UV spectroscopy show four absorption 
bands from 204-240 nm in UV spectrum as was shown by Yangyuoru et al [41], 
this band used as an indication of the gold oxidation state in complex , these 
bands were absent in UV of gold(III) complexes.  
Far infrared of phosphines complexes must be interpreted with caution 
because of the bending vibrations absorb lower than 550 cm-1 of Phenyl-P-Phenyl 
[130]. Far-IR data shows Au-C bond vibration frequency in K[Au(CN)4] complex at 
418 cm-1, while in K[Au(CN)2] show vibration frequency at 471cm-1 [127]. 
Difference in stretching bands between the two complexes is due to stronger 
Au(I)-C bond that cause shift to higher wave number, while the Au(III)-C bond is 
expected to be longer and a red shift was expected. This interpretation is fully 
consistent with the experimental results. This property could also be used as 
criteria to distinguish gold oxidation states in complexes. Table 4.28 shows blue 
shift of the Au-C stretching band in gold(I) complexes while red shift were 
observed for gold(III) complexes.  
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IR stretching band of P-S and P-Se [131] shows decrease in vibration 
frequency upon complexation. This could be due to electron donation from sulfur 
and selenium to the metal this enhance π-back donation and lead to more 
electron density on the π* orbital, that weaken P-S and P-Se bonds after 
complexation. 
13C and 31P NMR chemical shifts are given in Table 4.29. 13C NMR 
chemical shift of the cyanide ligand in complex was useful in the identification of 
gold oxidation state in complex. Canumalla et al [103] reported that cyanide signal 
in the complex Au(III)-CN appeared at ~115 for cis and 120 for trans in D2O for 
mono-substituted complex [LAu(CN)3] while at 125 ppm for the di-substituted 
complex [L2Au(CN)2]+, on the other hand, chemical shift for cyanide ligand 
attached to gold(I) as [Au(CN)2]- was reported to appear at 156 ppm in D2O [132] 
and found to be 152  ppm in CD3OD.  
31P NMR shows clear downfield shift for phosphines nuclei in complexes 
while no change in chemical shift by 13P NMR were found when L is phosphine 
sulphides or phosphine selenides. This could be due to longer distance between 
the phosphine and metal, compared to phosphine ligands. 
When gold(III) complexes were heated overnight at 60oC and their 13C 
NMR recorded, a resonance at 152 ppm appeared indicating reduction from 
gold(III) to gold(I) complexes.  
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Table 4.30: Solid-state 13C Isotropic Chemical Shifts (δiso) and Principle Shielding 
Tensors (σxx)a of cyanide in Gold(III)-tetracyanide complexes with 
phosphine ligands.  
Complex δisoa σ11 σ22 σ33 Span (Ω)b Skew 
 KAu(CN)4 110.0 236 138 -46 282 0.30 
(2-CN-Et)3P     122.9 231 207 -70 302 0.84 
[((2-CN-Et)3P)2AuCN] (i)  127.1 216 124 41 175 -0.05 
 (ii) 123.7 266 193 -88 354 0.59 
[(Me3PS)2Au(CN)2]CN  105.3 222 123 -29 250 0.22 
Ph3PS 120.4 235 133 -7 243 0.16 
[(Ph3PS)2Au(CN)3]  (i)  122.9 218 138 13 204 0.22 
 (ii) 128.5 220 149 17 203 0.30 
Ph3PSe 122.2 197 128 41 156 0.12 
[Ph3PSeAu(CN)3].KCN (i)  122.3 216 138 13 203 0.23 
 (ii) 125.2 204 142 30 173 0.28 
a δiso= (σ11+ σ22 + σ33) / 3, b Span (Ω) = σ33 - σ11 and c Skew (κ) = 3(σ22 – δiso) / Ω, 
[64,65,133,134] 
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Solid state 13C NMR data for the synthesized complexes are given table 
4.30. Cyanide isotropic signal shows downfield shift in complex by comparison 
with KAu(CN)4. In aryl- phosphine–gold complexes, cyanide 13C NMR signal 
are interfering with aromatic ring multiplets, which are more intense, because 
of the hydrogen attached to carbon. This increase signal intensity in the 
CPMAS experiment, while cyanide carbon signal was of less intensity and 
broader.  Downfield effect were observed in all complexes when compared to 
[Au(CN)4]- before reaction. The same results found in solution and solid NMR. 
Another observation is the higher downfield shift found in solid NMR as effect 
of solvent effect absence, so less shielded nuclei found by solid state NMR as 
expected.  
Solid state 31P NMR isotropic signal and tensors (σxx) are given Table 4.31, 
isotropic signal of the complex show clear shift in case phosphine ligands, that in 
the phosphine complex the phosphorus is directly attached to the Au and as such 
we expect the largest change [135], while minor change or no change were found 
for phosphine sulphides and phosphine selenides complexes that are distant from 
binding site, another explanation for this could be the presence of pπ-dπ bond that 
will lead to the increase in electron density around phosphorus, thus augmenting 
its shielding [124]. 
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  Table 4.31: Solid-state 31P NMR, isotropic chemical shifts (δiso) and principle 
shielding tensors (σxx)a  for gold(III)-tetracyanide complexes with 
phosphine ligands. 
Compound δiso σ11 σ22 σ33 Span (Ω)a Skew 
b (2-CN-Et)3P -32.2 -15 -41 -41 26 -1.00 
 [((2-CN-Et)3P)2AuCN] 49.5 130 82 -63 193 0.50 
 [(Cy3P)2AuCN].KCN 50.3 112 98 -59 171 0.83 
Et3PS 59.7 109 96 -25 134 0.80 
[(Et3PS)3Au(CN)3] 59.8 107 97 -25 131 0.85 
Ph3PS 45.3 112 
 
 
80 -56 167 0.62 
[(Ph3PS)2Au(CN)3] 45.4 107 86 -56 163 0.75 
Ph3PSe 36.8 111 51 -52 163 0.27 
[Ph3PSeAu(CN)3].KCN 36.8 96 60 -46 143 0.50 
a δiso= (σ11+ σ22 + σ33) / 3, b Span (Ω) = σ33 - σ11 and c Skew (κ) = 3(σ22 – δiso) / Ω, 
[64,65,133,134] 
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4.10 Gold(III)-tetracyanide interaction with imidazolidine-2-thione ligand and 
its derivatives. 
Interactions of gold(III)-tetracyanide with thione ligands were studied by mixing 
reactants at different ratios.  
Imt reaction with H2O2 was carried out in D2O and resulting spectra are 
presented in Figure 4.38, after oxidation signal at 179.6 ppm appeared in 
spectrum Figure 4.38b, that correspond to the C1 of the disulphide product, C2 
signal split into two non-equivalent carbons after oxidation to the disulphide and 
two signals appeared at 46.2 and 44.8 ppm. 
 
Scheme 4.26: Imt oxidation reaction by H2O2. 
 Figure 4.39 shows 13C NMR spectra for Imt reaction with [Au(CN)4]-, no 
reaction was observed after mixing of components in both; D2O and CD3OD 
solutions. However heating of sample overnight at 45 oC in methanol-d4 showed 
the formation of signal at 152 ppm that correspond to cyanide in [Au(CN)2]- 
complex,(Figure 4.39b).  
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Table 4.32: 13C NMR chemical shifts for thiones reaction with H2O2 and [Au(CN)4]- 
complex at 25 oC in D2O.  
Compound δ(CN) C1 C2 C3 Ref. 
KCN 164.49    [136] 
KAu(CN)2 154    [132] 
KAu(CN)4 104    [16,103] 
Imt - 182.08 45.37   
Imt + H2O2 - 179.63 46.21, 44.81   
KAu(CN)4 + Imt 153.60 181.30 44.56   
Diaz - 173.29 41.00 19.26 This work 
Diaz + H2O2 - 171.30, 161.25, 159.70 
40.11, 39.92, 
37.49 
25.73, 21.03, 
18.53  
KAu(CN)4 + Diaz 118.78 177.62 41.66 20.53  
Diap - 183.88 45.84 26.97 This work 
Diap + H2O2 - 174.50 47.37 27.01  
KAu(CN)4 + Diap 154.86, 134.55, 114.16, 112.96 186.04, 175.03 52-43 28-24  
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Table 4.33: 13C NMR chemical shifts for thiones reaction with [Au(CN)4]- complex 
at 25 oC in CD3OD.  
Compound  δ(CN), (ppm) C1 C2 C3 Ref. 
KCN 163.60    
This 
work 
KAu(CN)2 153.41    [137] 
KAu(CN)4 103.47    
This 
work 
Imt - 186.09 46.01  
This 
work 
KAu(CN)4 + Imt 152.53 185.31 46.03   
Diaz - 205.32 41.65 20.54 
This 
work 
KAu(CN)4 + Diaz 134.82, 118.92 162.34,158.89 40.12 21.14, 19.51  
Diap - 189.43 46.20 27.88 
This 
work 
KAu(CN)4 + Diap 
162,30, 153.06, 
134.28, 114.56 
171.32 45.98 30.92,27.42  
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Figure 4.39: 13C NMR spectra of (a) Imt before reaction, (b) after reaction with 
H2O2, at 25 oC. 
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Figure 4.40: 13C NMR spectrum for (a) Imt before reaction, (b) after reaction with 
[Au(CN)4]-, at 25 oC. 
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Figure 4.41: 13C NMR spectra of (a) Diaz before reaction, (b) 20 hours after 
reaction with K[Au(CN)4] and (c) after 2 day and after heated for 
overnight at 45 oC in CD3OD, at 25 oC.  
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 Diaz was reacted with [Au(CN)4]- in D2O and in CD3OD solution at 2:1 
ratios. In both solvents no reaction was observed only after heating overnight at 
45oC indication of low reactivity of Diaz against [Au(CN)4]-. However, after heated 
redox reaction was observed that produce [Au(CN)2]-, (152 ppm) while oxidation of 
Diaz ligand is expected. Diaz-C1 signal shifted ~ 7 ppm up-field after reaction 
indication of more shielding of thione carbon.       
 Reaction of Diaz with [Au(CN)4]- was repeated in D2O at 2:1 ratios. Signals 
at 118 ppm was detected by 13C NMR for cyanide, this was corresponding to 
[(Diaz)2Au(CN)2]+ , while C1 signal was shifted ~ 4 ppm downfield after reaction (δ 
= 178 ppm), corresponding chemical shifts are given in table 4.32.  
 Diaz reaction with H2O2 was carried out in D2O, produced spectra are given 
in figure 4.41. Up-field shift of C1 signal is observed in figure 4.41b after reaction 
with H2O2, indication of more shielding on C1. This could be interpreted by the 
partial positive charge formed at C1 carbon after the formation of disulphide. 
Electron resonance from neighboring nitrogen atoms can increase electron 
density at C1. Similar trend were found for other thione derivatives after reaction 
with H2O2. 
146 
 
 
 
 
 
Figure 4.42: 13C NMR spectra of (a) Diaz before reaction, (b) after reaction with 
H2O2, at 25 oC. 
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Figure 4.43: 1H NMR spectra for (a) Diap before reaction, (b) after reaction with 
K[Au(CN)4] in D2O, at 25 oC, pH = 7.4. 
148 
 
 
Figure 4.44: 13C NMR spectra of (a) Diap before reaction, (b) after reaction with 
K[Au(CN)4] in CD3OD, at 25 oC. 
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Diap was reacted with [Au(CN)4]- at 2:1 ratios in both; D2O and CD3OD. 
Resulting 1H and 13C NMR spectra are presented in Figures 4.42-4. 1H NMR 
spectra for diap reaction with K[Au(CN)4] in D2O are presented in Figure 4.42. 
After 9 hours (Figure 4.42b) several species were formed in solution. This 
indicates that Diap is more reactive than both Diaz and Imt ligand. However, 13C 
NMR spectra were more informative that showed several intermediates for Diap 
reaction with [Au(CN)4]-. 
 
Figure 4.43 shows the spectra of Diap reaction [Au(CN)4]- in methanol. In 
addition to non-reacted Diap, several species was detected by spectrum (Figure 
4.43b);  [Au(CN)2]- (152 ppm), free KCN (164 ppm), [(Diap)Au(CN)] (135 ppm for 
cyanide signal and at 171 for C1'). 
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Figure 4.45: 13C NMR spectra, (a) for Diap ligand before reaction, (b) after 9 
hours, in D2O at 25 oC, pH = 7.4. 
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Reaction of Diap with [Au(CN)4]- was repeated in D2O at 2:1 ratios. Similar 
species were obtained in aqueous, like in methanol, in addition to cyanogen at 
113 ppm and [(Diap)Au(CN)3] at 114 ppm. 
Diap exchanged cyanide ligand from gold(III)-tetracyanide complex. 
Multiplet signal at 113 ppm was attributed to cyanogen NCCN, which appear as a 
deceptive triplet due to fully labeled cyanogen which has a spin system of AA'XX'.  
The large one bond 13C-13C coupling in the spin system provides a deceptive 
triplet [43,44,114].  
 Doublet appear at 114 ppm was attributed to the mono-substituted 
complex, [(Diap)Au(CN)3] as shown by Yangyuoru et al [41]. Intense signal at 
~155 ppm appeared in D2O and 152 ppm in CD3OD solution that correspond to 
[Au(CN)2]- that produce after reduction of gold(III) into gold(I).  
 Diap oxidation by H2O2 in D2O was carried out and corresponding 13C NMR 
chemical shifts are given in Table 4.33 and reaction is the formation of the bis-
diap.  
 
Scheme 4.27: Diap oxidation by H2O2. 
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CHAPTER FIVE 
CONCLUSIONS 
5.1 Synthesis and characterization of gold(III)-alkyldiamine complexes and 
their interactions with biologically important ligands.    
1. Two series of gold(III) complexes were prepared with alkyldiamine ligands, the 
first contain various metalacycle rings of five to seven membered rings, the 
other contain N-mono and N,N'-disubstituted ethylenediamine ligands.  
2. Data collected from both solid and solution NMR were complementary, e. g. 
butylenediamine complex, 1c, showed four signals in both solid and solution 
13C NMR, that reveals folded geometry of lower symmetry level for the seven 
membered rings. 
3. 15N NMR showed that seven membered ring has the highest electron donation.  
4. Interaction of L-histidine and imidazole with [Au(en)Cl2]Cl complex in solution 
at different pD’s show [Au(en)Cl2]+ to be very stable at pD > 7.0 because of 
better donation through en ligand.  
5. Reaction of L-histidine with [Au(en)Cl2]+ starts by binding reaction of histidine 
with Au(III) metal ion, while L-histidine oxidation products was detected after  ~ 
1 hour.   
6. L-histidine binding reaction to [Au(en)Cl2]+ along with redox reaction were 
found to be directly proportional to solution pH.   
7. Gold(III) ion suggested to be encapsulated by L-histidine by legation through 
imidazole-Ns in η3 and amine-N as well as carboxylate group as counter ion. 
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This binding elucidates high gold histidine affinity, gold reduction and L-
histidine oxidation at C6 position.   
8. Increasing of the chelating alkyldiamine length in Au(III)-alkyldiamine complex, 
leads to the increase in reaction rate with L-histidine, i.e. bn > pn >> en.  
9. Reaction of L-histidine with [Au(en)Cl2]Cl was of first order with respect to each 
component at pH 2.9 and 25 oC.  
10. Thiols were found to react with [Au(en)Cl2]Cl, first by chloride ligand exchange 
by thiols then reductive elimination of the di-sulfide dimer, while Au(III) reduced 
into the Au(I) and en ligand dissociate from gold complex. 
11.  [Au(en)Cl2]Cl reaction with Met and Se-Met was found to proceed through the 
exchange of chloride ligands, gold(III) reduction then precipitation of polymeric 
gold(I)-Met and gold(I)-Se-Met along with release of the en ligand from the 
gold complex.  
12. Thio- and seleno-ethers react with [Au(en)Cl2]Cl first by hydrolysis step then 
solvent exchange reaction with the thio or seleno-ether, that followed by 
another hydrolysis step and reductive elimination of the sulphoxide or seleno-
oxide ligand from complex and lead finally to Au(III) reduction.  
5.2 Gold(III)-tetracyanide complex and its interactions with biologically 
important ligands. 
1. [Au(CN)4]- shows high reactivity toward thiols. At low thiol ratio, the reaction 
proceeds through exchange of one cyanide ligands followed by reductive 
elimination of the disulfide from two mono-substituted intermediates produce in 
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formation of di-sulfide and hexa-cyano-diaurate that disproportionates into 
auocyanide and auricyanide.  
2. At higher thiol ratio, reaction proceeds through two cyanide exchange followed 
by reductive elimination of the disulfide from cis-[(RS)2Au(CN)2]- intermediates 
along with Au(III) reduction to Au(I) in the form of [Au(CN)2]-.   
3. Met and Se-Met were inert toward auricyanide at pH=7.4 while some reactivity 
was observed for Se-Met at pH=12. 
4. Phosphine ligands can cause the gold(III) reduction into gold(I), while 
phosphine sulphides and phosphine selenides ligands exchange the cyanide 
ligands.  
5. IR,  Far-IR and UV spectroscopy can provide good and complementery data 
by which gold oxidation state could be characterized.  
6. Diap reaction with gold-tetracyanide was faster than Diaz, which was much 
faster than Imt. 
7. Thiones reaction with [Au(CN)4]- was dependent on solvent, that redox reaction 
takes place readily in aqueous solution rather than in methanol.  
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APPENDIX A - LIST OF ABBREVIATION 
2,4-DTU 2,4-dithiouracil 
AuSTg Gold thioglucose 
AuSTm Gold sodium thiomalate 
Autm Aurothiomalate 
bn Butylenediamine 
Cap L-Captopril 
Cap-S-S-Cap Captopril-disulfide 
cis-Pt Cisplatin 
Cys Cysteine 
CyS-SCy Cystine 
Diap Diazipane-2-thione 
Diaz Diazinane-2-thione 
DSS 2,2-Dimethylsilapentane-5-sulphonate 
en Ethylenediamine 
ErSH L-Ergothionene 
Et3PAuSATg Auranofin 
Gly Glycine 
GSH Glutathione 
GSSG Glutathione-S-S- Glutathione 
His L-Histidine 
HO-His 2-HO-histidine 
HO-Imi 2-Hydroxy-imidazole 
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Imi Imidazole 
Imt Imidazolidine-2-thione 
Imt-S-S-Imt Imt-di-sulfide 
Met L-methionine 
N,N' –Et2-en N,N’-di-ethyl-ethylenediamine 
N,N'-(2-hydroxy-Et)2-en N,N’-di-2-hydroxy-ethyl Ethylenediamine 
N,N'-iPr2-en N,N’-di-iso-propyl-ethylenediamine 
N,N'–Me2-en N,N’-di-methyl-ethylenediamine 
N-Et-en N-ethyl-ethylenediamine 
N-hydroxy-Et-en N-hydroxy-ethyl-ethylenediamine 
N-iPr-en N-iso-propyl-ethylenediamine 
N-Me-en N-methyl-ethylenediamine 
PaSH D-penicillamine 
pn Propylenediamine 
PaSH DL-penicillamine 
Se-Met DL-seleno-methionine 
TmSH Thiomalic acid 
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